{
  "title": "M21-1, Part V, Subpart iii, Chapter 1, Section B - Musculoskeletal Disabilities of the Extremities and Spine",
  "url": "https://www.knowva.ebenefits.va.gov/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000014410/M21-1-Part-V-Subpart-iii-Chapter-1-Section-B-Musculoskeletal-Disabilities-of-the-Extremities-and-Spine",
  "content": "<-- Previous Section\nNext Section -->\nOverview\nIn This Section\nThis section contains the following topics:\nTopic\nTopic Name\n1\nEvaluating Musculoskeletal Disabilities of the Arms\n2\nEvaluating Musculoskeletal Disabilities of the Hands\n3\nEvaluating Musculoskeletal Disabilities of the Spine\n4\nEvaluating Musculoskeletal Disabilities of the Legs\n5\nEvaluating Musculoskeletal Disabilities of the Feet\n1\n.\nEvaluating Musculoskeletal Disabilities of the Arms\nIntroduction\nThis topic contains information on evaluating musculoskeletal disabilities of the arms, including\nconsidering separate evaluations for disabilities of the shoulder and arm\nexample of separate evaluations for disabilities of the shoulder and arm\nassigning separate evaluations for disabilities of the elbow, forearm, and wrist\nexample of separate evaluations for multiple disabilities of the elbow, forearm, and wrist\n, and\nconsidering impairment of supination and pronation of the forearm\n.\nChange Date\nApril 13, 2018\nV.iii.1.B.1.a\n.\nConsidering Separate Evaluations for Disabilities of the Shoulder and Arm\nSeparate evaluations may be given for disabilities of the shoulder and arm under\n38 CFR 4.71a diagnostic codes (DCs) 5201, 5202, or 5203\nif the manifestations represent separate and distinct symptomatology that are neither duplicative nor overlapping.\nReference\n:  For more information concerning separate and distinct symptomatology, see\n38 CFR 4.14\n, and\nEsteban v. Brown\n, 6 Vet.App. 259 (1994)\nV.iii.1.B.1.b\n.\nExample of Separate Evaluations for Disabilities of the Shoulder and Arm\nSituation\n:  A Veteran was involved in an automobile accident that resulted in multiple injuries to the upper extremities.  The Veteran sustained the following injuries\na humeral fracture resulting in restriction of arm motion at shoulder level, and\na clavicular fracture resulting in malunion of the clavicle.\nResult\n:\nassign a 20-percent evaluation for the impairment of the humerus under\n38 CFR 4.71a, DC 5202-5201\n, and\nassign a separate 10-percent evaluation for malunion of the clavicle under\n38 CFR 4.71a, DC 5203\n.\nNotes\n:\nThe hyphenated evaluation DC is assigned under\n38 CFR 4.71a, DC 5202-5201\nbecause the humerus impairment affects range of motion (ROM).\nThe separate evaluation for the clavicle disability is warranted because this disability does not affect ROM.\nException\n:  Multiple evaluations cannot be assigned under\n38 CFR 4.71a, DC 5201\nfor limited flexion and abduction of the shoulder.\nReference\n:  For more information on evaluating shoulder conditions, see\nYonek v. Shinseki\n, 722 F.3d 1355 (Fed. Cir. 2013).\nV.iii.1.B.1.c\n.\nAssigning Separate Evaluations for Disabilities of the Elbow, Forearm, and Wrist\nImpairments of the elbow, forearm, and wrist will be assigned separate disability evaluations.  The motions of these joints are all viewed as clinically separate and distinct.  Assign separate evaluations for impairment under the following DCs:\nelbow\nflexion under\n38 CFR 4.71a, DC 5206\n, or\nextension under\n38 CFR 4.71a, DC 5207\nforearm supination and pronation under\n38 CFR 4.71a, DC 5213\n, and\nwrist flexion or ankylosis under\n38 CFR 4.71a, DC 5214\nor\n38 CFR 4.71a, DC 5215\n.\nNotes\n:\n38 CFR 4.59\nmay be applied separately to the elbow, the forearm, and the wrist to result in potentially three separate evaluations for painful motion when the evidence otherwise supports such a finding.  However,\n38 CFR 4.59\nmay only be applied once to the elbow and may not be separately applied to both elbow flexion and elbow extension.\nWhen examination or other evidence denotes pain present in the joint or periarticular region but does not delineate the specific motions in which pain is present\nand\nthere is a potential for a separate evaluation under\n38 CFR 4.59\nas discussed in\nM21-1, Part V, Subpart iii, 1.A.1\n, obtain a medical opinion to determine which motions are painful.  When the examiner cannot delineate which motions are associated with pain, resolve doubt in favor of the Veteran and consider painful motion to be present in the separate plane such as to allow assignment of the separate minimum compensable evaluation under\n38 CFR 4.59\n.\nReference\n:  For more information on assigning separate evaluations for elbow motion, see\nM21-1, Part V, Subpart iii, 1. A.3.c\n.\nV.iii.1.B.1.d\n.\nExample of Separate Evaluations for Disabilities of the Elbow, Forearm, and Wrist\nSituation\n:  A Veteran sustained multiple injuries to the right upper extremity in a vehicle rollover accident.  The following impairments are due to the service-connected (SC) injuries:\nelbow flexion limited to 90 degrees\nelbow extension limited to 45 degrees\nfull ROM on supination and pronation with painful supination, and\nfull ROM of the wrist with pain on dorsiflexion.\nResult\n:  Assign the following disability evaluations\n20-percent for limited elbow flexion under\n38 CFR 4.71a, DC 5206\n10-percent for limited elbow extension under\n38 CFR 4.71a, DC 5207\n10-percent for painful forearm supination\nunder\n38 CFR 4.71a, DC 5213\n, and\n10-percent for painful wrist motion under\n38 CFR 4.71a, DC 5215\n.\nExplanation\n:\nCompensable limitation of motion (LOM) of elbow flexion and extension is present.  Separate evaluations are warranted for elbow flexion and extension.\nMotion of the forearm is separate and distinct from elbow motion.  Therefore, a separate evaluation is warranted for painful supination.\nMotion of the wrist is separate and distinct from forearm motion.  Therefore, a separate evaluation is warranted for painful motion of the wrist.\nNote\n:  If elbow flexion is limited to 100 degrees and elbow extension is limited to 45 degrees, assign a single 20-percent disability evaluation under\n38 CFR 4.71a, DC 5208\n.\nReferences\n:  For more information on\nseparate evaluations for motion of a single joint, see\nVAOPGCPREC 9-2004\n, and\nM21-1, Part V, Subpart iii, 1.A.3.c\n, and\nseparate evaluations for the elbow, forearm, and wrist, see\nM21-1, Part V, Subpart iii, 1.B.1.c\n.\nV.iii.1.B.1.e\n.\nConsidering Impairment of Supination and Pronation of the Forearm\nWhen preparing ratings decisions involving impairment of supination and pronation of the forearm, consider the following facts:\nFull pronation is the position of the hand flat on a table.\nFull supination is the position of the hand palm up.\nWhen examining limitation of pronation, the\narc is from full supination to full pronation, and\nmiddle of the arc is the position of the hand, palm vertical to the table.\nAssign the lowest, 20-percent evaluation when pronation cannot be accomplished through more than the first three-quarters of the arc from full supination.\nDo\nnot\nassign a compensable evaluation for both limitation of pronation and limitation of supination of the same extremity.\nReference\n:  For more information on considering painful motion when assigning multiple LOM evaluations for a joint, see\nM21-1, Part V, Subpart iii, 1.A.3.e\n.\n2\n.\nEvaluating Musculoskeletal Disabilities of the Hands\nIntroduction\nThis topic contains information on evaluating musculoskeletal disabilities of the hands, including\nidentifying digits of the hand\nevaluating\namputations of multiple fingers\n, and\nankylosis of one or more fingers\ncompensable evaluations for the fingers\n, and\nrating Dupuytren’s contracture of the hand\n.\nChange Date\nFebruary 8, 2021\nV.iii.1.B.2.a\n.\nIdentifying Digits of the Hand\nFollow the guidelines listed below to accurately specify the injured digits of the hand.\nThe digits of the hand are identified as\nthumb\nindex\nlong\nring, or\nlittle.\nDo not use numerical designations for either the fingers or the joints of the fingers.\nEach digit, except the thumb, includes three phalanges\nthe proximal phalanx (closest to the wrist)\nthe middle phalanx, and\nthe distal phalanx (closest to the tip of the finger).\nThe joint between the proximal and middle phalanges is called the\nproximal interphalangeal\nor\nPIP\njoint.\nThe joint between the middle and distal phalanges is called the\ndistal interphalangeal\nor\nDIP\njoint.\nThe thumb has only two phalanges, the proximal phalanx and the distal phalanx.  Therefore, each thumb has only a single joint, called the\ninterphalangeal\nor\nIP\njoint.\nThe joints connecting the phalanges in the hands to the metacarpals are the\nmetacarpophalangeal\nor\nMCP\njoints.\nDesignate either right or left for the digits of the hand.\nNote\n:  If the location of the injury is unclear, obtain x-rays to clarify the exact point of injury.\nReferences\n:  For\nmore information on\ndetermining dominant handedness, see\n38 CFR 4.69\n, and\nthe normal anatomical position (also called position of function) of the hand and fingers and normal range of motion of the fingers, see Note 1 preceding\n38 CFR 4.71a, DC 5216\n, and\nan exhibit of the anatomy of the hand, see the illustration following\n38 CFR 4.71a, DC 5156\n.\nV.iii.1.B.2.b\n.\nEvaluating Amputations of Multiple Fingers\nConsider and apply the following principles as applicable when evaluating amputations of multiple fingers:\nAmputations other than at the PIP joints or through the proximal phalanges will be rated as ankylosis of the fingers.\nAmputations at distal joints, or through distal phalanges (other than negligible losses) will be rated as favorable ankylosis of the fingers.\nAmputation through middle phalanges will be rated as unfavorable ankylosis of the fingers.\nIf there is amputation or resection of metacarpal bones (where more than one-half the bone is lost) in multiple finger injuries, add (not combine) 10 percent to the specified evaluation for the finger amputations subject to the amputation rule (at the forearm level).\nWhen an evaluation is assigned under\n38 CFR 4.71a, DC 5126 to 5130\nthere will also be entitlement to special monthly compensation.\nLoss of use of the hand exists when no effective function remains other than that which would be equally well served by an amputation stump with a suitable prosthetic appliance.\nV.iii.1.B.2.c\n.\nEvaluating Ankylosis of One or More Fingers\nWhen considering an evaluation for ankylosis of the index, long, ring or little finger, evaluate as:\nfavorable ankylosis\nif\neither\nthe MCP\nor\nPIP joint is ankylosed,\nand\nthere is a gap of two inches (5.1 cm.)\nor less\nbetween the fingertip(s) and the proximal transverse crease of the palm, with the finger(s) flexed to the extent possible\nunfavorable ankylosis\nif\neither\nthe MCP\nor\nPIP joint is ankylosed,\nand\nthere is a gap of\nmore than\ntwo inches (5.1 cm.) between the fingertip(s) and the proximal transverse crease of the palm, with the finger(s) flexed to the extent possible,\nor\nboth\nthe MCP\nand\nPIP joints of a digit are ankylosed (even if each joint is individually fixed in a favorable position),\nor\namputation without metacarpal resection at the PIP joint or proximal thereto\n(\n38 CFR 4.71a, DC 5153 to 5156)\nif both the MCP and PIP joints of a digit are ankylosed,\nand\neither is in extension or full flexion,\nor\nthere is rotation or angulation of a bone.\nWhen considering an evaluation for ankylosis of the thumb, evaluate as:\nfavorable ankylosis\nif\neither\nthe carpometacarpal\nor\nIP joint is ankylosed,\nand\nthere is a gap of two inches (5.1 cm.)\nor less\nbetween the thumb pad and fingers with the thumb attempting to oppose the fingers\nunfavorable ankylosis\nif\neither\nthe carpometacarpal\nor\nIP joint is ankylosed,\nand\nthere is a gap of\nmore than\ntwo inches (5.1 cm.) between the thumbpad and the fingers, with the thumb attempting to oppose the fingers,\nor\nboth\nthe carpometacarpal\nand\nIP joints are ankylosed (even if each joint is individually fixed in a favorable position),\nor\namputation at the carpometacarpal joint or joints or through proximal phalange\n(\n38 CFR 4.71a, DC 5152)\nif both the carpometacarpal and IP joints are ankylosed,\nand\neither is in extension or full flexion,\nor\nthere is rotation or angulation of a bone.\nNote\n:  Only joints ankylosed in normal anatomical position as defined in Note 1 preceding\n38 CFR 4.71a, DC 5216\nare considered favorably ankylosed.\nReference\n:  For more information on evaluation of ankylosis of the fingers, see the notes prior to\n38 CFR 4.71a, DC 5216\n.\nV.iii.1.B.2.d\n.\nCompensable Evaluations for the Fingers\nWhen considering evaluations for the fingers based on LOM, a compensable evaluation can be assigned for any of the following:\nLOM of the thumb as specified in\n38 CFR 4.71a, DC 5228\n.\nLOM of the index or long finger as specified in\n38 CFR 4.71a, DC 5229\n.\nX-ray evidence of arthritis or other condition rated under the criteria of\n38 CFR 4.71a, DC 5003\n, affecting a\ngroup\nof minor joints of the fingers of\none\nhand.  There must be\nnoncompensable LOM in more than one of the joints comprising the group of affected minor joints,\nand\nfindings such as swelling, muscle spasm or satisfactory evidence of painful motion in the affected minor joints of the joint group.\nX-ray-\nonly\nevidence of arthritis (where there is no LOM) under the criteria of\n38 CFR 4.71a, DC 5003\n, affecting\ntwo or more\ngroups\nof minor joints – namely the fingers of\nboth\nhands or a group of minor joints in one hand in combination with another group of minor joints.\nPainful motion of the thumb, index finger, or long finger as directed at\nM21-1, Part V, Subpart iii, 1.A.1.l\n.\nNote\n:\nThe Federal Circuit held in\nSpicer v. Shinseki\n, 752 F.3d 1367 (Fed. Cir. 2014) that when evaluating arthritis of the hand, the minor joint\ngroup\nof IP joints of a hand is compensably disabled\nonly when two or more\njoints in the group are affected by LOM.  Refer to\nM21-1, Part V, Subpart iii, 1.A.3.a and b\nfor more information on the applicability of the\nSpicer\nholding.\nReferences\n:  For more information on\nuse of the terms major and minor when evaluating joints, see\nM21-1, Part V, Subpart iii, 1.A.3.a\nassigning evaluations under\n38 CFR 4.71a, DC 5003\nwhen a compensable rating based on LOM cannot be assigned under another DC, see\nM21-1, Part V, Subpart iii, 1.C.4.b\n, and\napplying\n38 CFR 4.59\nto minor joints, see\nM21-1, Part V, Subpart iii, 1.A.1.l\n.\nV.iii.1.B.2.e\n.\nRating Dupuytren’s Contracture of the Hand\nThe rating schedule does not specifically list Dupuytren’s contracture as a disease entity; therefore, assign an evaluation on the basis of limitation of finger movement.\n3\n.\nEvaluating Musculoskeletal Disabilities of the Spine\nIntroduction\nThis topic contains information on evaluating musculoskeletal disabilities of the spine, including\nevaluating manifestations of spine diseases and injuries\nvariations in terminology for intervertebral disc syndrome (IVDS)\ndefinition of incapacitating episode of IVDS\nobjective neurological impairment associated with spinal disabilities\nexamples addressing neurological impairments associated with spinal disabilities\ndisability benefits questionnaire (DBQ) selections for radiculopathy\nexample of evaluating IVDS\n, and\nevaluating ankylosing spondylitis\n.\nChange Date\nFebruary 27, 2025\nV.iii.1.B.3.a\n.\nEvaluating Manifestations of Spine Diseases and Injuries\nEvaluate diseases and injuries of the spine based on the criteria listed in the\n38 CFR 4.71a\n, General Rating Formula for Diseases and Injuries of the Spine (General Rating Formula).  Under these criteria, evaluate conditions based on chronic orthopedic manifestations (for example, painful muscle spasm or LOM) and any associated neurological manifestations (for example, footdrop, muscle atrophy, or sensory loss) by assigning separate evaluations for the orthopedic and neurological manifestations.\nEvaluate intervertebral disc syndrome\n(\nIVDS) under\n38 CFR 4.71a, DC 5243\n, either based on the General Rating Formula or the Formula for Rating IVDS Based on Incapacitating Episodes (Incapacitating Episode Formula), whichever formula results in the higher evaluation when all disabilities are combined under\n38 CFR 4.25\n.\nNotes\n:\nUtilize\n38 CFR 4.71a, DC 5243\nonly\nwhen there is disc herniation with compression and/or irritation of the adjacent nerve root.  Otherwise, assign\n38 CFR 4.71a, DC 5242\nfor all other disc diagnoses.\nIrritation of the adjacent nerve root is evidenced by back pain and sciatica (pain along the course of the sciatic nerve) in the case of lumbar disc diseases.  For cervical disc disease, neck and arm or hand pain will be shown.\nIf an evaluation is assigned based on incapacitating episodes, a separate evaluation may not be assigned for LOM, radiculopathy, or any other associated objective neurological abnormality as doing so would constitute pyramiding under\n38 CFR 4.14\n.\nSpinal fusion is a type of fixation of the spine.  Evaluation based on ankylosis of the spine due to fusion is only warranted when the fixation affects the entire thoracolumbar or cervical spine segment.  Fusion of only a portion of the cervical or thoracolumbar spine segment should be evaluated based on range or motion or IVDS, as warranted by the evidence.\nThere is no presumption of service connection (SC) for degenerative disc disease (DDD).  Desiccation of the disc or other degenerative changes without any radiographic evidence of arthritic changes is not indicative of arthritis and is not, consequently, subject to presumptive SC under\n38 CFR 3.309(a)\n.\nReferences\n:  For more information on\nevaluating\ndegenerative spinal disease, such as spondylosis, see\nM21-1, Part V, Subpart ii, 2.E.1.e\n, and\nCousin v. Wilkie\n, 905 F.3d 1316 (Fed.Cir. 2018), and\nco-existing SC and NSC disabilities affecting separate spinal segments, see\nM21-1, Part V, Subpart ii, 3.D.2.c\n, and\nLangdon v. McDonough\n, 1 F.4th 1008 (Fed. Cir. 2021), and\nthe historical application of\n38 CFR 4.40\n, and\n38 CFR 4.45\nto evaluations for IVDS, see\nVAOPGCPREC 36-1997\n, and\n38 CFR 4.71a, DC 5285\n, for demonstrable deformity of a vertebral body, see\nVAOPGCPREC 3-2006\n.\nV.iii.1.B.3.b\n.\nVariations in Terminology for IVDS\nVariations of diagnostic terminology exist for IVDS.  When used in the clinical setting, the following terminology is consistent with the general designation of IVDS:\nslipped or herniated disc\nruptured disc\nprolapsed disc\nbulging or protruded disc\nDDD\nsciatica\ndiscogenic pain syndrome\nherniated nucleus pulposus, and\npinched nerve.\nV.iii.1.B.3.c\n.\nDefinition:  Incapacitating Episode of IVDS\nBy definition, an incapacitating episode of IVDS requires bedrest prescribed by a physician.\nWhen evaluating IVDS based on incapacitating episodes, there must be evidence the associated symptoms required bedrest as prescribed by a physician.  The medical evidence of prescribed bedrest must be\nof record in the claims folder,\nor\nreviewed and described by an examiner completing an examination or disability benefits questionnaire (DBQ).\nNote\n:  If the records do not adequately document prescribed bedrest, use the General Rating Formula to evaluate IVDS and advise the Veteran to submit medical evidence documenting the periods of incapacitating episodes requiring bedrest prescribed by a physician.\nV.iii.1.B.3.d\n.\nObjective Neurological Impairment Associated With Spinal Disabilities\nObjective neurological abnormalities associated with spinal disabilities\nare evaluated separately from the spinal disability (\nexcept\n, as noted in\nM21-1, Part V, Subpart iii, 1.B.3.a\n, when IVDS is evaluated based on incapacitating episodes), and\nrepresent a medical progression or worsening of the spinal disease.\nFor that reason and because neurological complications of spinal disease are contemplated in the evaluation criteria for spinal conditions under\n38 CFR 4.71a\n, a claim asserting new complications of spinal disease is considered a claim for increase rather than a claim for secondary SC.\nWhen evaluating an expressly claimed spinal disability, decision makers must consider entitlement to compensation for any neurological complications as within scope of the claim in accordance with\nM21-1, Part V, Subpart ii, 3.A.2.c\n.\nLikewise, a primary spinal condition responsible for an expressly claimed neurological complication is considered within the scope of the expressly claimed issue, as discussed in\nM21-1, Part V, Subpart ii, 3.A.1.c\n.\nWhen assigning effective dates for neurological spinal complications, consider effective date provisions specifically for increases as specified in\nM21-1, Part V, Subpart ii, 4.A.5.e\n.\nNotes\n:\nWhen an SC thoracolumbar disability is present and objective neurological abnormalities or radiculopathy are diagnosed but the medical evidence does not identify a specific nerve root, rate the lower extremity radiculopathy under the sciatic nerve,\n38 CFR 4.124a, DC 8520\n.\nAdditional examinations of other body systems may be required if there are neurological complications of the peripheral nerves, bladder, and/or impairment of sphincter control.\nApply the previous provisions of historical\n38 CFR 3.157(b)\nwhen determining the effective date for neurological abnormalities of the spine that are identified by requisite records prior to March 24, 2015.\nExample\n:  Veteran has been SC for DDD since 2012.  Upon review of a claim for increase received on June 2, 2015, it is noted in Department of Veterans Affairs (VA) medical records that the Veteran received treatment for bladder impairment secondary to DDD on July 7, 2014.  Because the VA medical records constitute a claim for increase under rules in effect prior to March 24, 2015, it is permissible to apply previous rules from\n38 CFR 3.157 (b)\nin adjudicating the bladder impairment issue.\nReferences\n:  For more information on\nassigning disability evaluations for\nperipheral nerve disabilities, to include radiculopathy, see\nM21-1, Part V, Subpart iii, 12.A.2\n, and\nprogressive spinal muscular atrophy, see\nM21-1, Part V, Subpart iii, 12.A.1.c\nissues within the scope of a claim, see\n38 CFR 3.155(d)(2)\n, and\nM21-1, Part V, Subpart ii, 3.A.2\nassigning effective dates for neurological spinal complications, see\n38 CFR 3.400(o)\n38 CFR 3.155\n, and\nM21-1, Part V, Subpart ii, 4.A.1.g\n, and\nprocedural guidance on handling the effective dates and coding complications of an SC disability in Veterans Benefits Management System - Rating (VBMS-R), see\nM21-1, Part V, Subpart ii, 4.A.5.e\n.\nV.iii.1.B.3.e\n.\nExamples Addressing Neurological Impairments Associated With Spinal Disabilities\nExample 1\n:  A Veteran files a claim for an increased evaluation for the SC condition of spinal stenosis.  An intent to file (ITF) a claim was not received.  The DBQ shows decreased ROM of the spine that is unchanged from the prior evaluation and a diagnosis of radiculopathy of the bilateral lower extremities.  No other evidence indicates that radiculopathy was diagnosed prior to the date of this DBQ.  The rating activity should evaluate the spinal stenosis and grant SC for bilateral radiculopathy with an effective date assigned based on the receipt of the claim for the increased evaluation in the spinal stenosis.\nExample 2\n:  A Veteran submits a claim for SC of right leg pain and numbness, more than one year following discharge.  An ITF is not associated with this claim.  Development of the claim confirms a diagnosis of radiculopathy that is due to an unclaimed back injury.  The back injury was sustained in service.  Sufficient evidence to establish SC for the back disability is of record.  Consider the unclaimed back disability within scope of the claimed radiculopathy and establish SC for both issues with an effective date assigned based on the date of the receipt of the claim for SC of radiculopathy.\nExample 3\n:  The Veteran files a\nVA Form 21-526EZ, Application for Disability Compensation and Related Compensation Benefits\n, for an increased evaluation in an SC spinal disability.  In conjunction with that claim, the Veteran submits private medical records showing a diagnosis of radiculopathy, related to the SC spinal disability, within the last year.  An ITF is not associated with the claim.  The private medical evidence is sufficient to evaluate the radiculopathy but does not contain ROM findings for the lumbosacral spine.  The rating activity should grant SC for radiculopathy from the date of the diagnosis of radiculopathy (in accordance with\n38 CFR 3.400(o)(2)\n) and defer the evaluation of the spinal disability for an increase evaluation examination.\nV.iii.1.B.3.f\n.\nDBQ Selections for Radiculopathy\nRadiculopathy is a common type of neurological impairment associated with spinal disabilities.\nRefer to the table below to determine which DBQ to request when the claimed disability is a thoracolumbar/cervical spine condition and/or lumbar/cervical radiculopathy.\nIf the claimed condition is a/an ...\nThen, request the ...\nthoracolumbar spine condition (initial SC or increased evaluation) with or without a claim for radiculopathy\nBack (Thoracolumbar Spine) Conditions Disability Benefits Questionnaire\nwhen otherwise necessary to decide the claim.\nImportant\n:\nThe DBQ contains a section for radiculopathy that must be completed by the examiner if there is an indication of radiculopathy.\nIf the examiner fails to address radiculopathy, the examination must be returned as insufficient.\ncervical spine condition (initial SC or increased evaluation) with or without a claim for radiculopathy\nNeck (Cervical Spine) Conditions Disability Benefits Questionnaire\nwhen otherwise necessary to decide the claim.\nImportant\n:\nThe DBQ contains a section for radiculopathy that must be completed by the examiner if there is an indication of radiculopathy.\nIf the examiner fails to address radiculopathy, the examination must be returned as insufficient.\nincreased evaluation of\nlower extremity or lumbar radiculopathy, or\nupper extremity or cervical radiculopathy\nPeripheral Nerves Conditions (Not Including Diabetic Sensory-Motor Peripheral Neuropathy) Disability Benefits Questionnaire.\nupper extremity radiculopathy (initial SC) without a claim for cervical spine condition\nNeck (Cervical Spine) Disability Benefits Questionnaire\nImportant\n:  If the examiner fails to address radiculopathy, the examination must be returned as insufficient.\nlower extremity radiculopathy (initial SC) without a claim for thoracolumbar spine condition\nBack (Thoracolumbar Spine) Conditions Disability Benefits Questionnaire\nImportant\n:  If the examiner fails to address radiculopathy, the examination must be returned as insufficient.\nNote\n:  Do not routinely request an examination for an issue(s) for which the evidence of record is sufficient to make a decision.  This includes DBQs completed by a private or VA provider that are deemed adequate for rating purposes.\nReferences\n:  For more information on\ndetermining when an examination is necessary to decide a claim, see\nM21-1, Part IV, Subpart i, 1.A\nusing medical evidence in lieu of an examination, see\nM21-1, Part IV, Subpart i, 1.B.1.a\n, and\nsufficiency of examinations, see\nM21-1, Part IV, Subpart i, 3.A\n.\nV.iii.1.B.3.g\n.\nExample of Evaluating IVDS\nSituation\n:  A Veteran’s IVDS is being evaluated.\nLOM warrants a 20-percent evaluation under the General Rating Formula for Diseases and Injuries of the Spine\nmild radiculopathy of the left lower extremity warrants a 10-percent evaluation as a neurological complication (evidence of irritation of the adjacent nerve root) under\n38 CFR 4.124a, DC 8520\n, and\nmedical evidence shows incapacitating episodes requiring bedrest prescribed by a physician of four weeks duration over the past 12 months which would result in a 40-percent evaluation based on the incapacitating episode formula.\nResult\n:  Assign a 40-percent evaluation under\n38 CFR 4.71a, DC 5243\nbased on incapacitating episodes.\nExplanation\n:\nEvaluating IVDS using incapacitating episodes results in the highest evaluation.\nSince incapacitating episodes are used to evaluate IVDS, the associated LOM and neurological signs and symptoms will not be assigned a separate evaluation.\nV.iii.1.B.3.h\n.\nEvaluating Ankylosing Spondylitis\nAnkylosing spondylitis may be evaluated as an active disease process or based upon LOM of the spine.\nThe table below describes appropriate action for evaluating ankylosing spondylitis.\nIf ankylosing spondylitis is ...\nThen ...\nan active process\nevaluate under\n38 CFR 4.71a, DC 5009\n(using the criteria in\n38 CFR 4.71a, DC 5002\nfor the acute phase).\ninactive\nevaluate based on chronic residuals affecting the spine under\n38 CFR 4.71a, DC 5003 or DC 5240\n, and\nseparately evaluate other affected joints or body systems under the appropriate DC.\n4\n.\nEvaluating Musculoskeletal Disabilities of the Legs\nIntroduction\nThis topic contains information on evaluating musculoskeletal disabilities of the lower extremities (not including the feet), including\nevaluating noncompensable knee conditions\ndefinition of instability and subluxation of the knee\nevaluating instability of the knee\nseparate evaluations\nfor knee instability and LOM\n, and\nof meniscal disabilities\nexamples of evaluating meniscal disabilities\nseparate evaluations – genu recurvatum\nconservative therapy for shin splints\nevaluating pain associated with shin splints\n, and\nankle instability\n.\nChange Date\nApril 25, 2022\nV.iii.1.B.4.a\n.\nEvaluating Noncompensable Knee Conditions\nEvaluate a noncompensable knee condition by analogy to\n38 CFR 4.71a, DC 5257\nif\nthere is no associated arthritis\nthe schedular criteria for a noncompensable evaluation under\n38 CFR 4.71a, DC 5260\nor\nDC 5261\nare not met,\nand\nthe condition cannot be appropriately evaluated under\n38 CFR 4.71a, DC 5258, 5259, 5262, or 5263\n.\nReferences\n:  For more information on\nusing analogous DCs, see\n38 CFR 4.20\n, and\nwhen to assign a 0-percent evaluation, see\n38 CFR 4.31\n.\nV.iii.1.B.4.b\n.\nDefinitions:  Instability and Subluxation of the Knee\nInstability\n, as referred to in\n38 CFR 4.71a, DC 5257\n, includes\npatellar instability due to recurrent patellar subluxation or patellar dislocation, and/or\nany other instability or laxity of the knee that involves other stabilizing structure of the knee such as the collateral or cruciate ligaments.\nSubluxation\nrefers to partial or incomplete dislocation of the knee joint (\ntibiofemoral\ndislocation/subluxation) or tendency for the patella to dislocate from its track (\npatellar\ndislocation/subluxation).\nEvaluations under\n38 CFR 4.71a, DC 5257\nmay be assigned based on the requirement for assistive device(s) and/or bracing.  The assistive device or bracing must be prescribed by a medical provider and there must be objective evidence of the prescription in the evidentiary record.\nV.iii.1.B.4.c\n.\nEvaluating Instability of the Knee\nEvaluations for instability of the knee are assigned based on whether the instability arises from\nsprain or a ligament tear, or\npatellar instability.\nWhen there is persistent instability but the medical evidence and/or examination report does not identify the instability as related to either a ligament tear/sprain or a diagnosed condition involving the patellofemoral complex (such as instability due to osteoarthritis or osteoarthrosis), then evaluate it using the patellar instability criteria under\n38 CFR 4.71a, DC 5257\n.\nNote\n:  The presence of persistent instability is sufficient to satisfy the requirement of recurrent symptoms for the 10-percent evaluation.\nV.iii.1.B.4.d\n.\nSeparate Evaluations for Knee Instability and LOM\nA separate evaluation for knee instability may be assigned in addition to any evaluation(s) assigned based on limitation of knee motion.  The Office of General Counsel has issued precedent opinions that an evaluation under\n38 CFR 4.71a, DC 5257\n, does not pyramid with evaluations based on LOM.\nReferences\n:  For more information on\npyramiding and separating individual findings in a rating decision, see\nM21-1, Part V, Subpart ii, 3.D.2.b\nseparate evaluation of knee instability, see\nVAOPGCPREC 23-1997\n, and\nVAOPGCPREC 9-1998\n, and\nevaluation of joint replacement or resurfacing, see\nM21-1, Part V, Subpart iii, 1.A.3.h-j\n.\nV.iii.1.B.4.e\n.\nSeparate Evaluation of Meniscal Disabilities\nEvaluation of a knee disability under\n38 CFR 4.71a, DC 5257, DC 5260\n, or\n5261\ndoes not, as a matter of law, preclude separate evaluation of a meniscal disability of the same knee under\n38 CFR 4.71a, DC 5258\n(dislocated semilunar cartilage), or\n38 CFR 4.71a, DC 5259\n(symptomatic removal of semilunar cartilage).\nA meniscal disability may be rated separately under\n38 CFR 4.71a, DC 5258/5259\napart from\n38 CFR 4.71a, DC 5257\nfor manifestations of the knee disability other than recurrent subluxation and instability, and/or\n38 CFR 4.71a, DC 5260/5261\nif a manifestation of the meniscal disability did not result in an elevation of the disability evaluation warranted  under\n38 CFR 4.71a, DC 5260/5261\nvia application of\n38 CFR 4.40\nand\n38 CFR 4.45\npursuant to\nDeLuca v. Brown\n, 8 Vet.App. 202 (1995).\nImportant\n:\nA repaired meniscal tear (s/p partial meniscectomy) is not directly synonymous with either\n38 CFR 4.71a, DC 5258\nor\n38 CFR 4.71a, DC 5259\n.  Therefore, it is most appropriate to rate the disability analogous to whichever code most closely approximates the current symptoms.\nEntitlement to a separate evaluation for the meniscal disability depends on whether the manifestations are utilized to assign an evaluation under a different DC.  Evaluation of the same manifestation under multiple diagnoses is prohibited under\n38 CFR 4.14\n.  Thus, when all the symptoms of the meniscal disability are used to support elevation of an evaluation under\n38 CFR 4.71a, DC 5260/5261\nor assignment of an evaluation under\n38 CFR 4.71a, DC 5257\n, a separate evaluation cannot be assigned under\n38 CFR 4.71a, DC 5258/5259\n.\nWhen considering applicability of\n38 CFR 4.59\nfor meniscal disabilities,\nwhen\nonly\na meniscal disability is present, utilize the procedures at\nM21-1, Part V, Subpart iii, 1.A.1.m\n, and\nwhen multiple knee disabilities are present and the painful motion is attributable to a knee disability other than the meniscal condition, assign separate evaluations when otherwise warranted under\n38 CFR 4.14\n.\nThe policy and procedures identified in this block reflect a change in policy resulting from the holding in\nLyles v. Shulkin\n, 29 Vet.App. 107 (2017), effective November 29, 2017.  Prior to the\nLyles\nholding, separate evaluations for meniscal disabilities under\n38 CFR 4.71a, DC 5258\nor\nDC 5259\nand other knee evaluations under\n38 CFR 4.71a, DC 5257, 5260, or DC 5261\nwere prohibited.  This is not considered a liberalizing change.\nReferences\n:  For more information on\nevaluation of meniscal disabilities, see\nLyles v. Shulkin\n, 29 Vet.App. 107 (2017), and\nexamples of evaluation of meniscal disabilities, see\nM21-1, Part V, Subpart iii, 1.B.4.f\n.\nV.iii.1.B.4.f\n.\nExamples-- Evaluating Meniscal Disabilities\nExample 1\n:  A Veteran’s left knee disability, which includes a meniscal condition, is evaluated as 30-percent disabling on the basis of limitation of extension under\n38 CFR 4.71a, DC 5261\n.  The knee also manifests pain, swelling, popping, locking, and grinding due to the meniscus disability.  These symptoms, which are consistent with the manifestations identified under\n38 CFR 4.40\nand\n38 CFR 4.45\n, were considered and did not result in a higher evaluation under\n38 CFR 4.71a, DC 5261\n.  Therefore, they may be considered for assignment of a separate evaluation under\n38 CFR 4.71a, DC 5258/5259\n.\nExample 2\n:  The evaluations and fact pattern for Example 1 are the same\nexcept\nthat the VA examiner indicates that the pain, swelling, popping, locking, and grinding of the knee, which results from the meniscal disability, result in additional limitation of extension to 30 degrees during flare-ups or with repeated use over a period of time, which warrants an elevation of the rating to 40-percent under\n38 CFR 4.71a, DC 5261\n.  A separate evaluation under\n38 CFR 4.71a, DC 5258/5259\nis not warranted for the symptoms of pain, swelling, popping, locking, and grinding since these symptoms were considered under\n38 CFR 4.40\nand\n38 CFR 4.45\nin accordance with the\nDeLuca\nholding to elevate the evaluation to 40-percent under\n38 CFR 4.71a, DC 5261\n.  Assignment of a separate evaluation under\n38 CFR 4.71a, DC 5258/5259\nwould constitute pyramiding.\nExample 3\n:  A Veteran’s left knee disability, which includes meniscal impairment, is evaluated as 30-percent disabling on the basis of limitation of extension under\n38 CFR 4.71a, DC 5261\n.  Pain is present due to the meniscus disability.  A VA examiner indicated that pain during repetitive motion testing as well as functional loss due to pain during flare-ups additionally limit extension to 30 degrees, which results in elevation of the 30-percent evaluation under\n38 CFR 4.71a, DC 5261\nto 40-percent.  A separate evaluation under\n38 CFR 4.71a, DC 5258/5259\nis not warranted for the symptoms of pain since it was considered under\n38 CFR 4.40\nand\n38 CFR 4.45\nin accordance with the\nDeLuca\nholding to elevate the evaluation to 40-percent under\n38 CFR 4.71a, DC 5261\n.  Assignment of a separate evaluation under\n38 CFR 4.71a, DC 5258/5259\nwould constitute pyramiding.\nExample 4\n:  A Veteran’s right knee disability is evaluated as 20-percent disabling on the basis of limitation of extension.  This disability includes arthritis of the joint and a post-operative meniscal condition.  The knee also manifests pain, swelling, popping, locking, and grinding due to both arthritis and the meniscal condition.  A VA examiner found that repetitive motion testing additionally limited extension by five degrees, from 15 to 20 degrees, due to pain.  The consideration of pain on motion, which is a manifestation identified under\n38 CFR 4.40\nand\n38 CFR 4.45\n, results in elevation of the evaluation under\n38 CFR 4.71a, DC 5261\nto 30-percent.  Since the swelling, popping, locking, and grinding, which were at least in part due to the meniscal condition, were not considered in awarding a higher evaluation under\n38 CFR 4.71a, DC 5261\nwith application of\n38 CFR 4.40\nand\n38 CFR 4.45\n, a separate evaluation may be awarded for the meniscus removal.\nExample 5\n:  Examination of the left knee disability reveals an unrepaired incomplete ligament tear that results in persistent instability.  The Veteran’s physician has prescribed a brace and a cane for ambulation.  Additionally, the Veteran has a history of meniscectomy with residual symptoms of stiffness, crepitus, and pain without effusion or locking.  ROM is full with no additional functional impairment following repeated ROM testing.  Since the stiffness, crepitus, and pain are separate symptoms and not used to support an evaluation under\n38 CFR 4.71a, DC 5257/5260/5261\nand the persistent instability is not used to support an evaluation for the meniscal symptoms, a 20-percent evaluation is warranted under\n38 CFR 4.71a, DC 5257\nwith a separate 10-percent evaluation assigned under\n38 CFR 4.71a, DC 5259\n.\nV.iii.1.B.4.g\n.\nSeparate Evaluations – Genu Recurvatum\nWhen evaluating genu recurvatum, which involves hyperextension of the knee beyond 0 degrees of extension, under\n38 CFR 4.71a, DC 5263\ndo\nnot also\nevaluate separately under\n38 CFR 4.71a, DC 5261\n, but\ndo\nevaluate separately under other evaluations\nif\nmanifestations that are not overlapping, such as limitation of flexion under\n38 CFR 4.71a, DC 5260\n, are attributed to genu recurvatum, and\ndo\nnot\nevaluate separately under\n38 CFR 4.71a, DC 5257\n; however, if instability is manifested from genu recurvatum evaluate based on the criteria that will provide the highest evaluation.\nV.iii.1.B.4.h\n.\nConservative Therapy for Shin Splints\nUtilize\n38 CFR 4.71a, DC 5262\nfor evaluating impairment of the tibia and fibula including nonunion, malunion (evaluated under the corresponding knee or ankle codes based on associated impairment), or medial tibial stress syndrome (MTSS).\nEvaluations for MTSS may be based on the use of conservative treatment.  For this purpose, conservative treatment includes but is not limited to treatment of symptoms using the following:\nrest\nice\nelevation\nmedication\ncompression socks, and/or\nmassage.\nNote\n:  MTSS is synonymous with shin splints.  Related assessments, such as compartment syndrome and/or stress fractures, may also appear in treatment records.  When compartment syndrome is the predominant diagnosis, however, a rating under\n38 CFR 4.73, DC 5331\nis warranted.\nV.iii.1.B.4.i\n.\nEvaluating Pain Associated With Shin Splints\nMTSS, or shin splints, is a type of  joint or periarticular pathology which is a requirement for application of\n38 CFR 4.59\n, for assignment of the minimum compensable evaluation under\n38 CFR 4.71a, DC 5262\nwhen painful motion is shown and shin splints are otherwise noncompensable.  The following principles apply:\nShin splints with pain that is not associated with motion, such as pain on palpation, are noncompensable under\n38 CFR 4.59\n.\nThe minimum compensable evaluation is warranted when painful motion due to shin splints occurs in nearby affected joints such as the ankle or knee or when shin pain or other similar pain occurs with motion.  However, when a separate knee or ankle disability exists and has been compensably evaluated, do not assign a compensable evaluation under\n38 CFR 4.59\nfor shin splints causing painful motion in an already-compensable SC knee or ankle joint.\nReference\n:  For more information on the applicability of\n38 CFR 4.59\nto ratings for shin splints, see\nM21-1, Part V, Subpart iii, 1.A.1.i\n, and\nSouthall-Norman v. McDonald\n, 28 Vet.App. 346 (2016).\nV.iii.1.B.4.j\n.\nAnkle Instability\nDo not assign separate evaluations for LOM and instability of the ankle.\nThe intent of the ankle DCs, including\n38 CFR 4.71a, DC 5271\n, is to address the overall ankle disability without limiting the focus to one specific type of ankle symptomatology.\nAlthough\n38 CFR 4.71a, DC 5271\nis titled,\nAnkle, limited motion of\nand utilizes objective ROM measurements to guide the decision maker as to the meaning of marked and moderate in evaluating symptoms, this DC may also be used to rate instability of the ankle with or without associated LOM.\nNote\n:\n38 CFR 4.20\nprovides that when a condition is not listed in the rating schedule, an analogous rating is to be assigned.  Based on the facts found, the DC most appropriate to the findings and that results in the highest evaluation should be selected.\nReference\n:   For more information on analogous ratings, see\nM21-1, Part V, Subpart ii, 3.D.1.c\n, and\nM21-1, Part V, Subpart iv, 1.C.2.a and b\n.\n5\n.\nEvaluating Musculoskeletal Disabilities of the Feet\nIntroduction\nThis topic contains information on evaluating musculoskeletal disabilities of the feet, including\nselecting a DC for foot disabilities\nidentifying the digits of the foot\nassigning separate evaluations for multiple foot disabilities\nevaluating\narthritis of the minor joints of the toes\n, and\nplantar fasciitis\ndefinition of metatarsalgia or Morton’s disease\n, and\nevaluating\nmetatarsalgia or Morton’s disease\n, and\nmetatarsalgia and\nplantar fasciitis\n, and\npes planus\n.\nChange Date\nFebruary 8, 2021\nV.iii.1.B.5.a\n.\nSelecting a DC for Foot Disabilities\nFoot injuries are rated under\n38 CFR 4.71a, DC 5284\n.  The application of this DC is limited to disabilities resulting from actual injuries to the foot, as opposed to disabilities caused by, for example, degenerative conditions.  However, conditions that are not specifically listed under\n38 CFR 4.71a, DC 5284\nmay be rated by analogy under DC 5284.\n38 CFR 4.71a, DC 5284\ndoes not apply to the other conditions of the foot specifically listed under\n38 CFR 4.71a, DCs 5276 through 5283 and 5269\n.  The listed conditions must be rated under the specified DCs and cannot be rated by analogy under\n38 CFR 4.71a, DC 5284\n.\nIn cases where a foot injury\nand\neither arthritis or another foot disability is involved\nconsider functional impairment, and\ndetermine whether, depending on the nature of the disability and history of injury, it is more advantageous to evaluate the condition under\n38 CFR 4.71a, DC 5284\nor another DC.\nReminder\n:  Consider the guidance in\nM21-1, Part V, Subpart iv, 1.C.4.b\nconcerning applicability of the bilateral factor when a DC provides one evaluation for a bilateral condition.\nReferences\n:  For more information on\nlimited applicability of\n38 CFR 4.71a, DC 5284\nto foot injuries, see\nYancy v. McDonald\n, 27 Vet.App. 484 (2016)\nprohibition of evaluating specific foot disabilities otherwise listed in\n38 CFR 4.71a\nanalogously under\n38 CFR 4.71a, DC 5284\n, see\nCopeland v. McDonald\n, 27 Vet.App. 333 (2015)\n, and\napplying\n38 CFR 4.59\nto disabilities of minor joints, see\nM21-1, Part V, Subpart iii, 1.A.1.l\n.\nV.iii.1.B.5.b\n.\nIdentifying the Digits of the Foot\nFollow the guidelines listed below to accurately specify the injured digits of the foot.\nRefer to the digits of the foot as\nfirst or great toe\nsecond\nthird\nfourth, or\nfifth.\nEach digit, except the great toe, includes three phalanges\nthe proximal phalanx (closest to the ankle)\nthe middle phalanx, and\nthe distal phalanx (closest to the tip of the toe).\nThe joint between the proximal and middle phalanges is called the\nproximal  interphalangeal\n(PIP) joint.\nThe joint between the middle and distal phalanges is called the\ndistal interphalangeal\n(DIP) joint.\nThe great toes each have only two phalanges, the proximal phalanx and the distal phalanx.  Therefore, each great toe has only a single joint, called the\ninterphalangeal\n(IP) joint.\nThe joints connecting the phalanges in the feet to the metatarsals are the\nmetatarsophalangeal\n(MTP) joints.\nDesignate either right or left for the digits of the foot.\nNote\n:  If the location of the injury is unclear, obtain x-rays to clarify the exact point of injury.\nV.iii.1.B.5.c\n.\nAssigning Separate Evaluations for Multiple Foot Disabilities\n38 CFR 4.14\nrequires that the evaluation of the same disability and/or the same manifestation under various diagnoses is to be avoided.\nThe compact anatomical structure of the foot as well as the inter-related physiological functioning may make it difficult to differentiate the etiology of certain disability symptoms.  When multiple SC foot disabilities are present but the etiology of the symptoms cannot be separated, assign a single disability evaluation for the predominant symptoms.\nIf, however, the etiology of the symptoms can be delineated, separate disability evaluations may be assigned under multiple DCs for foot disabilities provided that the principles of\n38 CFR 4.14\nhave not been violated.\nReference\n:  For more information on evaluating SC and non-service-connected (NSC) symptoms that cannot be separated, see\nM21-1, Part V, Subpart ii, 3.D.2.c\n.\nV.iii.1.B.5.d\n.\nEvaluating Arthritis of the Minor Joints of the Toes\nFor guidance on evaluating arthritis of a group of minor joints of the toes refer to the table below.\nIf arthritis ...\nThen ...\nis degenerative\naffects a group of minor joints in one foot\nis documented by x-ray evidence\nresults in LOM,\nand\nis confirmed by satisfactory evidence of painful motion, pain on use or other findings such as swelling\nassign a 10-percent evaluation under\n38 CFR 4.71a, DC 5003\n.\nis degenerative\naffects minor joint groups in\nboth\nfeet,\nand\nis documented by x-ray evidence,\nbut\ndoes not result in LOM\nassign a 10-percent evaluation under\n38 CFR 4.71a, DC 5003\n.\nException\n:  Assign a 20-percent evaluation if there are occasional incapacitating exacerbations).\nis post-traumatic\nevaluate under\n38 CFR 4.71a, DC 5010-5284\nwith consideration given to\n38 CFR 4.59\nwhen warranted.\nReferences\n:  For more information on\nassigning evaluations under\n38 CFR 4.71a, DC 5003\nwhen a compensable rating cannot be assigned under a DC for LOM of a joint, see\nM21-1, Part V, Subpart iii, 1.C.4.b\n, and\nconsidering painful motion when evaluating functional loss for purpose of applying\n38 CFR 4.71a, DC 5003\n, pursuant to the holding in\nMitchell v. Shinseki\n, 25 Vet.App. 32 (2011), see\nM21-1, Part V, Subpart iii, 1.A.1.e\n.\nV.iii.1.B.5.e\n.\nEvaluating Plantar Fasciitis\nEvaluate plantar fasciitis under\n38 CFR 4.71a, DC 5269\n.\nThe most common symptom seen with plantar fasciitis is heel pain.  The following considerations apply when evaluating the heel pain.\nWhen painful motion with joint or periarticular pathology is present and is a symptom of the plantar fasciitis,\n38 CFR 4.59\nis applicable.  However,  at least a 10-percent evaluation would most often be warranted under\n38 CFR 4.71a, DC 5269\nwithout consideration of\n38 CFR 4.59\n.\nWhen SC is established for pes planus and plantar fasciitis, evaluate the symptoms of both conditions together under the DC warranting the highest evaluation for the combined impairment.\nPes planus is characterized by pain on manipulation and use of the feet or other foot pain as included in the higher evaluation criteria.  The evaluation criteria for pes planus and plantar fasciitis are similar enough that providing separate evaluations will compensate the same facet of disability, foot pain, violating the prohibition against pyramiding in\n38 CFR 4.14\n.\nIf, however, one or both conditions resulted from an injury to the foot, an evaluation for the combined conditions under\n38 CFR 4.71a, DC 5284\nmay be assigned in lieu of evaluation under either the pes planus or plantar fasciitis criteria when doing so is  more advantageous.\nReference\n:  For more information on rating by analogy, see\nM21-1, Part V, Subpart iv, 1.C.2\n, and\nM21-1, Part V, Subpart ii, 3.D.1.c\n.\nV.iii.1.B.5.f\n.\nDefinition of Metatarsalgia or Morton’s Disease\nMetatarsalgia\nmeans pain in the forefoot – under the metatarsal heads.\nMorton’s Disease\nor\nMorton’s Neuroma\nrefers to a painful lesion of a plantar interdigital nerve.\nV.iii.1.B.5.g\n.\nEvaluating Metatarsalgia or Morton’s Disease\nAnterior metatarsalgia of any type, to include cases due to Morton’s Disease, will be evaluated under\n38 CFR 4.71a, DC 5279\n.\nThe DC provides for an evaluation of 10 percent regardless of whether the condition is unilateral or bilateral.\nV.iii.1.B.5.h\n.\nEvaluating Metatarsalgia and Plantar Fasciitis\nSince metatarsalgia refers to pain in the forefoot while plantar fasciitis is associated with pain in the heel, the symptoms should generally not overlap and separate evaluations may be assigned\nunless\nassessment of the evidence reveals that separate evaluation would be in violation of the pyramiding rules at\n38 CFR 4.14\n.\nV.iii.1.B.5.i\n.\nEvaluating Metatarsalgia and Pes Planus\nDo not assign separate evaluations for pes planus and metatarsalgia.\nPes planus is accompanied by pain on manipulation and use of the feet or other foot pain, as included in the higher evaluation criteria.  The evaluation criteria are similar enough that providing separate evaluations will compensate the same facet of disability, foot pain, violating the prohibition against pyramiding in\n38 CFR 4.14\n.\nAssign a single evaluation for pes planus with metatarsalgia using the predominant DC.\nDo not rate by analogy when there is an applicable DC.\nIf, however, one or both conditions resulted from an injury to the foot,  an evaluation for the combined conditions under\n38 CFR 4.71a, DC 5284\nmay be assigned in lieu of evaluation under either the pes planus or metatarsalgia criteria when doing so is more advantageous.\n<-- Previous Section\nNext Section -->\nTo Top",
  "content_html": "<div class=\"article-content\">\n<div compile-custom=\"article.content\" ng-aria=\"articleContent\"><p class=\"ng-scope\"></p><p class=\"ng-scope\" style=\"text-align: right\"><span style=\"font-size: 11px\"><span style=\"font-family: arial , helvetica , sans-serif\"><a articleid=\"554400000014407\" articlename=\"M21-1, Part V, Subpart iii, Chapter 1, Section A - Painful Motion and Functional Loss\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000014407/M21-1-Part-V-Subpart-iii-Chapter-1-Section-A-Painful-Motion-and-Functional-Loss\">&lt;-- Previous Section</a>  <a articleid=\"554400000014413\" articlename=\"M21-1, Part V, Subpart iii, Chapter 1, Section C - Arthritis\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000014413/M21-1-Part-V-Subpart-iii-Chapter-1-Section-C-Arthritis\">Next Section --&gt;</a></span></span></p><h2 class=\"ng-scope\"><a id=\"top\" name=\"top\"><span style=\"font-size: 16px\"><span style=\"font-family: arial , helvetica , sans-serif\">Overview</span></span></a></h2><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">In This Section</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; vertical-align: top; padding: 0px;\"><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">This section contains the following topics:</span></span></div><div></div><table border=\"1\" cellpadding=\"1\" cellspacing=\"1\" style=\"width: 512px; border-spacing: 1px; border-collapse: revert;\" summary=\"Column 1 has the topic number and column 2 has the topic title.\"><thead><tr><th scope=\"col\" style=\"width: 80px; vertical-align: top; padding: 1px;\"><div style=\"text-align: center\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><strong>Topic</strong></span></span></div></th><th scope=\"col\" style=\"width: 516px; vertical-align: top; padding: 1px;\"><div style=\"text-align: center\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><strong>Topic Name</strong></span></span></div></th></tr></thead><tbody><tr><td style=\"width: 80px; vertical-align: top; padding: 1px;\"><div style=\"text-align: center\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">1</span></span></div></td><td style=\"width: 516px; vertical-align: top; padding: 1px;\"><div><a href=\"#1\" target=\"_self\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Evaluating Musculoskeletal Disabilities of the Arms</span></span></a></div></td></tr><tr><td style=\"width: 80px; vertical-align: top; padding: 1px;\"><div align=\"center\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">2</span></span></div></td><td style=\"width: 516px; vertical-align: top; padding: 1px;\"><div><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#2\" target=\"_self\"><span style=\"font-size: 14px\">Evaluating Musculoskeletal Disabilities of the Hands</span></a></span></div></td></tr><tr><td style=\"width: 80px; vertical-align: top; padding: 1px;\"><div align=\"center\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">3</span></span></div></td><td style=\"width: 516px; vertical-align: top; padding: 1px;\"><div><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#3\" target=\"_self\"><span style=\"font-size: 14px\">Evaluating Musculoskeletal Disabilities of the Spine</span></a></span></div></td></tr><tr><td style=\"width: 80px; vertical-align: top; padding: 1px;\"><div align=\"center\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">4</span></span></div></td><td style=\"width: 516px; vertical-align: top; padding: 1px;\"><div><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#4\" target=\"_self\"><span style=\"font-size: 14px\">Evaluating Musculoskeletal Disabilities of the Legs</span></a></span></div></td></tr><tr><td style=\"width: 80px; vertical-align: top; padding: 1px;\"><div align=\"center\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">5</span></span></div></td><td style=\"width: 516px; vertical-align: top; padding: 1px;\"><div><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#5\" target=\"_self\"><span style=\"font-size: 14px\">Evaluating Musculoskeletal Disabilities of the Feet </span></a></span></div></td></tr></tbody></table><div><span style=\"font-family: arial, helvetica, sans-serif\"> </span></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><div class=\"ng-scope\" style=\"margin-left: 85pt\"></div><div class=\"ng-scope\" style=\"margin-left: 85pt\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"> </span></span></div><h2 class=\"ng-scope\"><span style=\"font-size: 16px\"><span style=\"font-family: arial , helvetica , sans-serif\">1<a id=\"1\" name=\"1\">.</a>  Evaluating Musculoskeletal Disabilities of the Arms</span></span></h2><p class=\"ng-scope\"><br/> </p><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Introduction</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">This topic contains information on evaluating musculoskeletal disabilities of the arms, including</span></span></div><ul><li><div><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#1a\" target=\"_self\"><span style=\"font-size: 14px\">considering separate evaluations for disabilities of the shoulder and arm</span></a></span></div></li><li><div><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#1b\" target=\"_self\"><span style=\"font-size: 14px\">example of separate evaluations for disabilities of the shoulder and arm</span></a></span></div></li><li><div><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#1c\" target=\"_self\"><span style=\"font-size: 14px\">assigning separate evaluations for disabilities of the elbow, forearm, and wrist</span></a></span></div></li><li><div><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#1d\" target=\"_self\"><span style=\"font-size: 14px\">example of separate evaluations for multiple disabilities of the elbow, forearm, and wrist</span></a><span style=\"font-size: 14px\">, and</span></span></div></li><li><div><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#1e\" target=\"_self\"><span style=\"font-size: 14px\">considering impairment of supination and pronation of the forearm</span></a>.</span></div></li></ul></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Change Date</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">April 13, 2018</span></span></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">V.iii.1.B.1.a<a id=\"1a\" name=\"1a\">.</a>  Considering Separate Evaluations for Disabilities of the Shoulder and Arm</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Separate evaluations may be given for disabilities of the shoulder and arm under <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=06267d0544c9650e626f1fe90192edac&amp;node=se38.1.4_171a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.71a diagnostic codes (DCs) 5201, 5202, or 5203</a> if the manifestations represent separate and distinct symptomatology that are neither duplicative nor overlapping.</span></span></div><div></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><strong><em>Reference</em></strong>:  For more information concerning separate and distinct symptomatology, see</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=70df8a154d2bdffaab9f94956057a637&amp;node=se38.1.4_114&amp;rgn=div8\" target=\"_blank\">38 CFR 4.14</a>, and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><a articleid=\"554400000066775\" articlename=\"Esteban v. Brown, February 25, 1994, 6 Vet.App. 259 (1994)\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000066775/Esteban-v-Brown-February-25-1994-6-VetApp-259-1994\"><em>Esteban v. Brown</em></a>, 6 Vet.App. 259 (1994)</span></span></div></li></ul></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">V.iii.1.B.1.b<a id=\"1b\" name=\"1b\">.</a>  Example of Separate Evaluations for Disabilities of the Shoulder and Arm</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><strong><em>Situation</em></strong>:  A Veteran was involved in an automobile accident that resulted in multiple injuries to the upper extremities.  The Veteran sustained the following injuries </span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">a humeral fracture resulting in restriction of arm motion at shoulder level, and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">a clavicular fracture resulting in malunion of the clavicle.</span></span></div></li></ul><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><strong><em>Result</em></strong>:</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">assign a 20-percent evaluation for the impairment of the humerus under <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=13bcad22732de2e24d3da7cad62932d5&amp;node=se38.1.4_171a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.71a, DC 5202-5201</a>, and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">assign a separate 10-percent evaluation for malunion of the clavicle under <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=13bcad22732de2e24d3da7cad62932d5&amp;node=se38.1.4_171a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.71a, DC 5203</a>.</span></span></div></li></ul><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><strong><em>Notes</em></strong>:</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">The hyphenated evaluation DC is assigned under <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=13bcad22732de2e24d3da7cad62932d5&amp;node=se38.1.4_171a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.71a, DC 5202-5201</a> because the humerus impairment affects range of motion (ROM).</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">The separate evaluation for the clavicle disability is warranted because this disability does not affect ROM. </span></span></div></li></ul><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><strong><em>Exception</em></strong>:  Multiple evaluations cannot be assigned under <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=13bcad22732de2e24d3da7cad62932d5&amp;node=se38.1.4_171a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.71a, DC 5201</a> for limited flexion and abduction of the shoulder. </span></span></div><div></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><strong><em>Reference</em></strong>:  For more information on evaluating shoulder conditions, see <em><a href=\"http://vbaw.vba.va.gov/bl/21/advisory/CAVCDAD.htm#bmy\" target=\"_blank\">Yonek v. Shinseki</a></em>, 722 F.3d 1355 (Fed. Cir. 2013).</span></span></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">V.iii.1.B.1.c<a id=\"1c\" name=\"1c\">.</a>  Assigning Separate Evaluations for Disabilities of the Elbow, Forearm, and Wrist</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Impairments of the elbow, forearm, and wrist will be assigned separate disability evaluations.  The motions of these joints are all viewed as clinically separate and distinct.  Assign separate evaluations for impairment under the following DCs:</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">elbow </span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">flexion under <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=e946814d91c13a689fba4efddae34bc3&amp;mc=true&amp;node=se38.1.4_171a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.71a, DC 5206</a>, or</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">extension under <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=e946814d91c13a689fba4efddae34bc3&amp;mc=true&amp;node=se38.1.4_171a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.71a, DC 5207</a></span></span></div></li></ul></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">forearm supination and pronation under <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=e946814d91c13a689fba4efddae34bc3&amp;mc=true&amp;node=se38.1.4_171a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.71a, DC 5213</a>, and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">wrist flexion or ankylosis under <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=e946814d91c13a689fba4efddae34bc3&amp;mc=true&amp;node=se38.1.4_171a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.71a, DC 5214</a> or <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=e946814d91c13a689fba4efddae34bc3&amp;mc=true&amp;node=se38.1.4_171a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.71a, DC 5215</a>.</span></span></div></li></ul><div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>Notes</em></strong>: </span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"https://www.ecfr.gov/cgi-bin/retrieveECFR?gp=&amp;SID=dcc466c3e069a06e73c46e3cc158e2b8&amp;mc=true&amp;n=sp38.1.4.b&amp;r=SUBPART&amp;ty=HTML#se38.1.4_159\" target=\"_blank\">38 CFR 4.59</a> may be applied separately to the elbow, the forearm, and the wrist to result in potentially three separate evaluations for painful motion when the evidence otherwise supports such a finding.  However, <a href=\"https://www.ecfr.gov/cgi-bin/retrieveECFR?gp=&amp;SID=dcc466c3e069a06e73c46e3cc158e2b8&amp;mc=true&amp;n=sp38.1.4.b&amp;r=SUBPART&amp;ty=HTML#se38.1.4_159\" target=\"_blank\">38 CFR 4.59</a> may only be applied once to the elbow and may not be separately applied to both elbow flexion and elbow extension. </span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">When examination or other evidence denotes pain present in the joint or periarticular region but does not delineate the specific motions in which pain is present <strong><em>and</em></strong> there is a potential for a separate evaluation under <a href=\"https://www.ecfr.gov/cgi-bin/retrieveECFR?gp=&amp;SID=dcc466c3e069a06e73c46e3cc158e2b8&amp;mc=true&amp;n=sp38.1.4.b&amp;r=SUBPART&amp;ty=HTML#se38.1.4_159\" target=\"_blank\">38 CFR 4.59</a> as discussed in <a articleid=\"554400000014407\" articlename=\"M21-1, Part V, Subpart iii, Chapter 1, Section A - Painful Motion and Functional Loss\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000014407/M21-1-Part-V-Subpart-iii-Chapter-1-Section-A-Painful-Motion-and-Functional-Loss\">M21-1, Part V, Subpart iii, 1.A.1</a>, obtain a medical opinion to determine which motions are painful.  When the examiner cannot delineate which motions are associated with pain, resolve doubt in favor of the Veteran and consider painful motion to be present in the separate plane such as to allow assignment of the separate minimum compensable evaluation under <a href=\"https://www.ecfr.gov/cgi-bin/retrieveECFR?gp=&amp;SID=dcc466c3e069a06e73c46e3cc158e2b8&amp;mc=true&amp;n=sp38.1.4.b&amp;r=SUBPART&amp;ty=HTML#se38.1.4_159\" target=\"_blank\">38 CFR 4.59</a>.</span></span></div></li></ul></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><strong><em>Reference</em></strong>:  For more information on assigning separate evaluations for elbow motion, see <a articleid=\"554400000014407\" articlename=\"M21-1, Part V, Subpart iii, Chapter 1, Section A - Painful Motion and Functional Loss\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000014407/M21-1-Part-V-Subpart-iii-Chapter-1-Section-A-Painful-Motion-and-Functional-Loss\">M21-1, Part V, Subpart iii, 1. A.3.c</a>.</span></span></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">V.iii.1.B.1.d<a id=\"1d\" name=\"1d\">.</a>  Example of Separate Evaluations for Disabilities of the Elbow, Forearm, and Wrist</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><strong><em>Situation</em></strong>:  A Veteran sustained multiple injuries to the right upper extremity in a vehicle rollover accident.  The following impairments are due to the service-connected (SC) injuries:</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">elbow flexion limited to 90 degrees</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">elbow extension limited to 45 degrees</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">full ROM on supination and pronation with painful supination, and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">full ROM of the wrist with pain on dorsiflexion.</span></span></div></li></ul><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><strong><em>Result</em></strong>:  Assign the following disability evaluations</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">20-percent for limited elbow flexion under <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=13bcad22732de2e24d3da7cad62932d5&amp;node=se38.1.4_171a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.71a, DC 5206</a></span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">10-percent for limited elbow extension under <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=13bcad22732de2e24d3da7cad62932d5&amp;node=se38.1.4_171a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.71a, DC 5207</a></span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">10-percent for painful forearm supination <span style=\"font-family: arial, helvetica, sans-serif\">under </span></span></span><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=2dd5087eef182bbdf97785fdbb1c3381&amp;node=se38.1.4_171a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.71a, DC 5213</a></span></span><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">, and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">10-percent for painful wrist motion under <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=13bcad22732de2e24d3da7cad62932d5&amp;node=se38.1.4_171a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.71a, DC 5215</a>.</span></span></div></li></ul><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><strong><em>Explanation</em></strong>:</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Compensable limitation of motion (LOM) of elbow flexion and extension is present.  Separate evaluations are warranted for elbow flexion and extension.</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Motion of the forearm is separate and distinct from elbow motion.  Therefore, a separate evaluation is warranted for painful supination.</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Motion of the wrist is separate and distinct from forearm motion.  Therefore, a separate evaluation is warranted for painful motion of the wrist. </span></span></div></li></ul><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><strong><em>Note</em></strong>:  If elbow flexion is limited to 100 degrees and elbow extension is limited to 45 degrees, assign a single 20-percent disability evaluation under <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=13bcad22732de2e24d3da7cad62932d5&amp;node=se38.1.4_171a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.71a, DC 5208</a>.</span></span></div><div></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><strong><em>References</em></strong>:  For more information on</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">separate evaluations for motion of a single joint, see</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><a articleid=\"554400000043930\" articlename=\"VAOPGCPREC 09-04, Sep 17, 2004, Rating Limitation of Flexion and Extension of the Leg\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000043930/VAOPGCPREC-09-04-Sep-17-2004-Rating-Limitation-of-Flexion-and-Extension-of-the-Leg\">VAOPGCPREC 9-2004</a>, and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><a articleid=\"554400000014407\" articlename=\"M21-1, Part V, Subpart iii, Chapter 1, Section A - Painful Motion and Functional Loss\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000014407/M21-1-Part-V-Subpart-iii-Chapter-1-Section-A-Painful-Motion-and-Functional-Loss\">M21-1, Part V, Subpart iii, 1.A.3.c</a></span></span><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">, and</span></span></div></li></ul></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">separate evaluations for the elbow, forearm, and wrist, see <a href=\"#1c\" target=\"_self\">M21-1, Part V, Subpart iii, 1.B.1.c</a></span></span><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">.</span></span></div></li></ul></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">V.iii.1.B.1.e<a id=\"1e\" name=\"1e\">.</a>  Considering Impairment of Supination and Pronation of the Forearm</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">When preparing ratings decisions involving impairment of supination and pronation of the forearm, consider the following facts:</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Full pronation is the position of the hand flat on a table.</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Full supination is the position of the hand palm up.</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">When examining limitation of pronation, the</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">arc is from full supination to full pronation, and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">middle of the arc is the position of the hand, palm vertical to the table.</span></span></div></li></ul></li></ul><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Assign the lowest, 20-percent evaluation when pronation cannot be accomplished through more than the first three-quarters of the arc from full supination.</span></span></div><div></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Do <em>not</em> assign a compensable evaluation for both limitation of pronation and limitation of supination of the same extremity.</span></span></div><div></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><strong><em>Reference</em></strong>:  For more information on considering painful motion when assigning multiple LOM evaluations for a joint, see <a articleid=\"554400000014407\" articlename=\"M21-1, Part V, Subpart iii, Chapter 1, Section A - Painful Motion and Functional Loss\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000014407/M21-1-Part-V-Subpart-iii-Chapter-1-Section-A-Painful-Motion-and-Functional-Loss\">M21-1, Part V, Subpart iii, 1.A.3.e</a>.</span></span></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><div class=\"ng-scope\" style=\"margin-left: 85pt\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"> </span></span><br/> </div><div class=\"ng-scope\"><h2><span style=\"font-size: 16px\"><span style=\"font-family: arial, helvetica, sans-serif\">2<a id=\"2\" name=\"2\">.</a>  Evaluating Musculoskeletal Disabilities of the Hands</span></span></h2></div><div class=\"ng-scope\"></div><div class=\"ng-scope\"></div><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Introduction</span></span></div></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">This topic contains information on evaluating musculoskeletal disabilities of the hands, including </span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#2a\" target=\"_self\">identifying digits of the hand</a></span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">evaluating </span></span></div><ul><li><div><a href=\"#2b\" target=\"_self\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">amputations of multiple fingers</span></span></a>, and</div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#2c\" target=\"_self\">ankylosis of one or more fingers</a></span></span></div></li></ul></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#2d\" target=\"_self\">compensable evaluations for the fingers</a>, and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#2e\" target=\"_self\">rating Dupuytren’s contracture of the hand</a>. </span></span></div></li></ul></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Change Date</span></span></div></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">February 8, 2021</span></span></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">V.iii.1.B.2.a<a id=\"2a\" name=\"2a\">.</a>  Identifying Digits of the Hand</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Follow the guidelines listed below to accurately specify the injured digits of the hand.</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">The digits of the hand are identified as</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">thumb</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">index</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">long</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">ring, or</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">little.</span></span></div></li></ul></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Do not use numerical designations for either the fingers or the joints of the fingers.</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Each digit, except the thumb, includes three phalanges</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">the proximal phalanx (closest to the wrist)</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">the middle phalanx, and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">the distal phalanx (closest to the tip of the finger).</span></span></div></li></ul></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">The joint between the proximal and middle phalanges is called the <em><strong>proximal interphalangeal</strong></em> or <strong><em>PIP</em></strong> joint.</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">The joint between the middle and distal phalanges is called the <em><strong>distal interphalangeal</strong></em> or <strong><em>DIP </em></strong>joint. </span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">The thumb has only two phalanges, the proximal phalanx and the distal phalanx.  Therefore, each thumb has only a single joint, called the <em><strong>interphalangeal</strong></em> or <em><strong>IP</strong></em> joint.</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">The joints connecting the phalanges in the hands to the metacarpals are the <em><strong>metacarpophalangeal</strong></em> or <strong><em>MCP</em></strong> joints.</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Designate either right or left for the digits of the hand.</span></span></div></li></ul><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><strong><em>Note</em></strong>:  If the location of the injury is unclear, obtain x-rays to clarify the exact point of injury.</span></span></span></span></div><div></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>References</em></strong>:  For </span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">more information on </span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">determining dominant handedness, see <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=0d5268726d8c1566de1c1953d5a9c573&amp;node=se38.1.4_169&amp;rgn=div8\" target=\"_blank\">38 CFR 4.69</a>, and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">the normal anatomical position (also called position of function) of the hand and fingers and normal range of motion of the fingers, see Note 1 preceding <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=1fb629056852366ecec871c9d143e8a8&amp;mc=true&amp;node=se38.1.4_171a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.71a, DC 5216</a>, and</span></span></div></li></ul></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">an exhibit of the anatomy of the hand, see the illustration following <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=1fb629056852366ecec871c9d143e8a8&amp;mc=true&amp;node=se38.1.4_171a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.71a, DC 5156</a>.</span></span></div></li></ul></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">V.iii.1.B.2.b<a id=\"2b\" name=\"2b\">.</a>  Evaluating Amputations of Multiple Fingers</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Consider and apply the following principles as applicable when evaluating amputations of multiple fingers:</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Amputations other than at the PIP joints or through the proximal phalanges will be rated as ankylosis of the fingers. </span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Amputations at distal joints, or through distal phalanges (other than negligible losses) will be rated as favorable ankylosis of the fingers. </span></span></span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Amputation through middle phalanges will be rated as unfavorable ankylosis of the fingers.</span></span></span></span></span></span></div></li></ul></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">If there is amputation or resection of metacarpal bones (where more than one-half the bone is lost) in multiple finger injuries, add (not combine) 10 percent to the specified evaluation for the finger amputations subject to the amputation rule (at the forearm level).</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">When an evaluation is assigned under <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=1fb629056852366ecec871c9d143e8a8&amp;mc=true&amp;node=se38.1.4_171a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.71a, DC 5126 to 5130</a> there will also be entitlement to special monthly compensation. </span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Loss of use of the hand exists when no effective function remains other than that which would be equally well served by an amputation stump with a suitable prosthetic appliance.</span></span></span></span></div></li></ul></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">V.iii.1.B.2.c<a id=\"2c\" name=\"2c\">.</a>  Evaluating Ankylosis of One or More Fingers</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">When considering an evaluation for ankylosis of the index, long, ring or little finger, evaluate as:</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><em>favorable ankylosis</em> if <strong><em>either</em></strong> the MCP <strong><em>or</em></strong> PIP joint is ankylosed, <strong><em>and</em></strong> there is a gap of two inches (5.1 cm.) <strong><em>or less</em></strong> between the fingertip(s) and the proximal transverse crease of the palm, with the finger(s) flexed to the extent possible</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><em>unfavorable ankylosis</em> if</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>either</em></strong> the MCP <strong><em>or</em></strong> PIP joint is ankylosed, <strong><em>and</em></strong> there is a gap of <strong><em>more than</em></strong> two inches (5.1 cm.) between the fingertip(s) and the proximal transverse crease of the palm, with the finger(s) flexed to the extent possible, <strong><em>or</em></strong></span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>both</em></strong> the MCP <strong><em>and</em></strong> PIP joints of a digit are ankylosed (even if each joint is individually fixed in a favorable position), <strong><em>or</em></strong></span></span></div></li></ul></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><em>amputation without metacarpal resection at the PIP joint or proximal thereto</em> (<a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=1fb629056852366ecec871c9d143e8a8&amp;mc=true&amp;node=se38.1.4_171a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.71a, DC 5153 to 5156)</a> if both the MCP and PIP joints of a digit are ankylosed, <em>and</em> either is in extension or full flexion, <em>or</em> there is rotation or angulation of a bone.</span></span></div></li></ul><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">When considering an evaluation for ankylosis of the thumb, evaluate as:</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><em>favorable ankylosis</em> if <strong><em>either</em></strong> the carpometacarpal <strong><em>or</em></strong> IP joint is ankylosed, <strong><em>and</em></strong> there is a gap of two inches (5.1 cm.) <strong><em>or less</em></strong> between the thumb pad and fingers with the thumb attempting to oppose the fingers</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><em>unfavorable ankylosis</em> if</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>either</em></strong> the carpometacarpal <strong><em>or</em></strong> IP joint is ankylosed, <strong><em>and</em></strong> there is a gap of <strong><em>more than</em></strong> two inches (5.1 cm.) between the thumbpad and the fingers, with the thumb attempting to oppose the fingers, <strong><em>or</em></strong></span></span></div></li><li><div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>both</em></strong> the carpometacarpal <strong><em>and</em></strong> IP joints are ankylosed (even if each joint is individually fixed in a favorable position), <strong><em>or</em></strong></span></span></div></div></li></ul></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><em>amputation at the carpometacarpal joint or joints or through proximal phalange</em> (<a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=1fb629056852366ecec871c9d143e8a8&amp;mc=true&amp;node=se38.1.4_171a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.71a, DC 5152)</a> if both the carpometacarpal and IP joints are ankylosed, <em>and</em> either is in extension or full flexion, <em>or</em> there is rotation or angulation of a bone.</span></span></div></li></ul><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>Note</em></strong>:  Only joints ankylosed in normal anatomical position as defined in Note 1 preceding <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=1fb629056852366ecec871c9d143e8a8&amp;mc=true&amp;node=se38.1.4_171a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.71a, DC 5216</a> are considered favorably ankylosed. </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>Reference</em></strong>:  For more information on evaluation of ankylosis of the fingers, see the notes prior to <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=1fb629056852366ecec871c9d143e8a8&amp;mc=true&amp;node=se38.1.4_171a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.71a, DC 5216</a>. </span></span></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">V.iii.1.B.2.d<a id=\"2d\" name=\"2d\">.</a>  Compensable Evaluations for the Fingers </span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><p><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">When considering evaluations for the fingers based on LOM, a compensable evaluation can be assigned for any of the following:</span></span></p><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">LOM of the thumb as specified in <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=1fb629056852366ecec871c9d143e8a8&amp;mc=true&amp;node=se38.1.4_171a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.71a, DC 5228</a>.</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">LOM of the index or long finger as specified in <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=1fb629056852366ecec871c9d143e8a8&amp;mc=true&amp;node=se38.1.4_171a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.71a, DC 5229</a>.</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">X-ray evidence of arthritis or other condition rated under the criteria of <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=1fb629056852366ecec871c9d143e8a8&amp;mc=true&amp;node=se38.1.4_171a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.71a, DC 5003</a>, affecting a <em>group</em> of minor joints of the fingers of <em>one</em> hand.  There must be</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">noncompensable LOM in more than one of the joints comprising the group of affected minor joints, <em>and</em></span></span></span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">findings such as swelling, muscle spasm or satisfactory evidence of painful motion in the affected minor joints of the joint group.</span></span></span></span></span></span></div></li></ul></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">X-ray-<em>only</em> evidence of arthritis (where there is no LOM) under the criteria of <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=1fb629056852366ecec871c9d143e8a8&amp;mc=true&amp;node=se38.1.4_171a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.71a, DC 5003</a>, affecting <em>two or more</em> <em>groups</em> of minor joints – namely the fingers of <em>both</em> hands or a group of minor joints in one hand in combination with another group of minor joints.</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Painful motion of the thumb, index finger, or long finger as directed at <a articleid=\"554400000014407\" articlename=\"M21-1, Part V, Subpart iii, Chapter 1, Section A - Painful Motion and Functional Loss\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000014407/M21-1-Part-V-Subpart-iii-Chapter-1-Section-A-Painful-Motion-and-Functional-Loss\">M21-1, Part V, Subpart iii, 1.A.1.l</a>.</span></span></div></li></ul><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><em><strong>Note</strong></em>:  <span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">The Federal Circuit held in <a articleid=\"554400000016346\" articlename=\"Spicer v. Shinseki, May 30, 2014, 752 F.3d 1367\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000016346/Spicer-v-Shinseki-May-30-2014-752-F3d-1367\"><em>Spicer v. Shinseki</em></a>, 752 F.3d 1367 (Fed. Cir. 2014) that when evaluating arthritis of the hand, the minor joint <em>group</em> of IP joints of a hand is compensably disabled <em>only when two or more</em> joints in the group are affected by LOM.  Refer to <a articleid=\"554400000014407\" articlename=\"M21-1, Part V, Subpart iii, Chapter 1, Section A - Painful Motion and Functional Loss\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000014407/M21-1-Part-V-Subpart-iii-Chapter-1-Section-A-Painful-Motion-and-Functional-Loss\">M21-1, Part V, Subpart iii, 1.A.3.a and b</a> for more information on the applicability of the <em>Spicer </em>holding.  </span></span></span></span></div><div></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>References</em></strong>:  For more information on</span></span></span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">use of the terms major and minor when evaluating joints, see <a articleid=\"554400000014407\" articlename=\"M21-1, Part V, Subpart iii, Chapter 1, Section A - Painful Motion and Functional Loss\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000014407/M21-1-Part-V-Subpart-iii-Chapter-1-Section-A-Painful-Motion-and-Functional-Loss\">M21-1, Part V, Subpart iii, 1.A.3.a</a></span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">assigning evaluations under <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=2ec7350adee36049b3011df9cfd38f55&amp;node=se38.1.4_171a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.71a, DC 5003</a> when a compensable rating based on LOM cannot be assigned under another DC, see <a articleid=\"554400000014413\" articlename=\"M21-1, Part V, Subpart iii, Chapter 1, Section C - Arthritis\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000014413/M21-1-Part-V-Subpart-iii-Chapter-1-Section-C-Arthritis\">M21-1, Part V, Subpart iii, 1.C.4.b</a>, and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">applying <a href=\"https://www.ecfr.gov/cgi-bin/retrieveECFR?gp=&amp;SID=dcc466c3e069a06e73c46e3cc158e2b8&amp;mc=true&amp;n=sp38.1.4.b&amp;r=SUBPART&amp;ty=HTML#se38.1.4_159\" target=\"_blank\">38 CFR 4.59</a> to minor joints, see <a articleid=\"554400000014407\" articlename=\"M21-1, Part V, Subpart iii, Chapter 1, Section A - Painful Motion and Functional Loss\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000014407/M21-1-Part-V-Subpart-iii-Chapter-1-Section-A-Painful-Motion-and-Functional-Loss\">M21-1, Part V, Subpart iii, 1.A.1.l</a>.</span></span></div></li></ul></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">V.iii.1.B.2.e<a id=\"2e\" name=\"2e\">.</a>  Rating Dupuytren’s Contracture of the Hand</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; vertical-align: top; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">The rating schedule does not specifically list Dupuytren’s contracture as a disease entity; therefore, assign an evaluation on the basis of limitation of finger movement.</span></span></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><h4 class=\"ng-scope\"></h4><h2 class=\"ng-scope\"><br/><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><span style=\"font-size: 16px\">3<a id=\"3\" name=\"3\">.</a>  Evaluating Musculoskeletal Disabilities of the Spine</span></span></span></h2><p class=\"ng-scope\"><br/> </p><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Introduction</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">This topic contains information on evaluating musculoskeletal disabilities of the spine, including</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#3a\" target=\"_self\">evaluating manifestations of spine diseases and injuries</a></span></span></div></li><li><div><a href=\"#3b\" target=\"_self\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">variations in terminology for intervertebral disc syndrome (IVDS)</span></span></a></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#3c\" target=\"_self\">definition of incapacitating episode of IVDS</a></span></span></div></li><li><div><a href=\"#3d\" target=\"_self\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">objective neurological impairment associated with spinal disabilities</span></span></a></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><a href=\"#3e\" target=\"_self\">examples addressing neurological impairments associated with spinal disabilities</a></span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><a href=\"#3f\" target=\"_self\">disability benefits questionnaire (DBQ) selections for radiculopathy</a></span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#3g\" target=\"_self\">example of evaluating IVDS</a>, and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#3h\" target=\"_self\">evaluating ankylosing spondylitis</a>.</span></span></div></li></ul></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Change Date</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; vertical-align: top; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">February 27, 2025</span></span></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">V.iii.1.B.3.a<a id=\"3a\" name=\"3a\">.</a>  Evaluating Manifestations of Spine Diseases and Injuries</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Evaluate diseases and injuries of the spine based on the criteria listed in the <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=13bcad22732de2e24d3da7cad62932d5&amp;node=se38.1.4_171a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.71a</a>, General Rating Formula for Diseases and Injuries of the Spine (General Rating Formula).  Under these criteria, evaluate conditions based on chronic orthopedic manifestations (for example, painful muscle spasm or LOM) and any associated neurological manifestations (for example, footdrop, muscle atrophy, or sensory loss) by assigning separate evaluations for the orthopedic and neurological manifestations.</span></span></div><div></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Evaluate intervertebral disc syndrome<strong> (</strong>IVDS) under <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=70df8a154d2bdffaab9f94956057a637&amp;node=pt38.1.4&amp;rgn=div5#se38.1.4_171a\" target=\"_blank\">38 CFR 4.71a, DC 5243</a>, either based on the General Rating Formula or the Formula for Rating IVDS Based on Incapacitating Episodes (Incapacitating Episode Formula), whichever formula results in the higher evaluation when all disabilities are combined under <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=40fc1e088ec92f168f9d24242bd432e7&amp;mc=true&amp;node=se38.1.4_125&amp;rgn=div8\" target=\"_blank\">38 CFR 4.25</a>.</span></span></div><div></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>Notes</em></strong>: </span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Utilize <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=13bcad22732de2e24d3da7cad62932d5&amp;node=se38.1.4_171a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.71a, DC 5243</a> <em>only</em> when there is disc herniation with compression and/or irritation of the adjacent nerve root.  Otherwise, assign <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=13bcad22732de2e24d3da7cad62932d5&amp;node=se38.1.4_171a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.71a, DC 5242</a> for all other disc diagnoses.</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Irritation of the adjacent nerve root is evidenced by back pain and sciatica (pain along the course of the sciatic nerve) in the case of lumbar disc diseases.  For cervical disc disease, neck and arm or hand pain will be shown.</span></span></div></li><li><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\">If an evaluation is assigned based on incapacitating episodes, a separate evaluation may not be assigned for LOM, radiculopathy, or any other associated objective neurological abnormality as doing so would constitute pyramiding under <a href=\"https://www.ecfr.gov/current/title-38/section-4.14\" target=\"_blank\">38 CFR 4.14</a>.</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Spinal fusion is a type of fixation of the spine.  Evaluation based on ankylosis of the spine due to fusion is only warranted when the fixation affects the entire thoracolumbar or cervical spine segment.  Fusion of only a portion of the cervical or thoracolumbar spine segment should be evaluated based on range or motion or IVDS, as warranted by the evidence.</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">There is no presumption of service connection (SC) for degenerative disc disease (DDD).  Desiccation of the disc or other degenerative changes without any radiographic evidence of arthritic changes is not indicative of arthritis and is not, consequently, subject to presumptive SC under <a href=\"https://www.ecfr.gov/cgi-bin/text-idx?SID=38d7ed71833e3104d61f4357b9e82e8f&amp;mc=true&amp;node=se38.1.3_1309&amp;rgn=div8\" target=\"_blank\">38 CFR 3.309(a)</a>.</span></span></div></li></ul><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><strong><em>References</em></strong>:  For more information on </span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">evaluating </span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">degenerative spinal disease, such as spondylosis, see</span></span></div><ul><li><div><a articleid=\"554400000180485\" articlename=\"M21-1, Part V, Subpart ii, Chapter 2, Section E - Service Connection (SC) for Congenital, Developmental, or Hereditary Disorders\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000180485/M21-1-Part-V-Subpart-ii-Chapter-2-Section-E-Service-Connection-SC-for-Congenital-Developmental-or-Hereditary-Disorders\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">M21-1, Part V, Subpart ii, 2.E.1.e</span></span></a><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">, and</span></span></div></li><li><div><a articleid=\"554400000096205\" articlename=\"Cousin v. Wilkie, Sep 28, 2018, 905 F. 3d 1316 (Fed. Cir. 2018)\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000096205/Cousin-v-Wilkie-Sep-28-2018-905-F-3d-1316-Fed-Cir-2018\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><em>Cousin v. Wilkie</em></span></span></a><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">, 905 F.3d 1316 (Fed.Cir. 2018), and</span></span></div></li></ul></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">co-existing SC and NSC disabilities affecting separate spinal segments, see</span></span></div><ul><li><div><a articleid=\"554400000180489\" articlename=\"M21-1, Part V, Subpart ii, Chapter 3, Section D - Evaluating Disabilities\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000180489/M21-1-Part-V-Subpart-ii-Chapter-3-Section-D-Evaluating-Disabilities\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">M21-1, Part V, Subpart ii, 3.D.2.c</span></span></a><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">, and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><em><a articleid=\"554400000195275\" articlename=\"Langdon v. McDonough, June 9, 2021, 1 F.4th 1008\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000195275/Langdon-v-McDonough-June-9-2021-1-F4th-1008\">Langdon v. McDonough</a></em>, 1 F.4th 1008 (Fed. Cir. 2021), and</span></span></div></li></ul></li></ul></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">the historical application of </span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=70df8a154d2bdffaab9f94956057a637&amp;node=se38.1.4_140&amp;rgn=div8\" target=\"_blank\">38 CFR 4.40</a>, and  <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=70df8a154d2bdffaab9f94956057a637&amp;node=se38.1.4_145&amp;rgn=div8\" target=\"_blank\">38 CFR 4.45</a> to evaluations for IVDS, see <a articleid=\"554400000043730\" articlename=\"VAOPGCPREC 36-97, Dec 12, 1997, Applicability of 38 CFR §§ 4.40, 4.45, and 3.321(b)(1) in Rating Disability Under Diagnostic Code 5293 (Intervertebral Disc Syndrome)\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000043730/VAOPGCPREC-36-97-Dec-12-1997-Applicability-of-38-CFR-440-445-and-3321b1-in-Rating-Disability-Under-Diagnostic-Code-5293-Intervertebral-Disc-Syndrome\">VAOPGCPREC 36-1997</a>, and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><a href=\"http://www.gpo.gov/fdsys/pkg/CFR-2003-title38-vol1/pdf/CFR-2003-title38-vol1-part4.pdf\" target=\"_blank\">38 CFR 4.71a, DC 5285</a>, for demonstrable deformity of a vertebral body, see <a articleid=\"554400000043942\" articlename=\"VAOPGCPREC 03-06, Jun 23, 2006, Multiple Ratings under Former 38 CFR 4.71a, Diagnostic Code 5285 (2003)\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000043942/VAOPGCPREC-03-06-Jun-23-2006-Multiple-Ratings-under-Former-38-CFR-471a-Diagnostic-Code-5285-2003\">VAOPGCPREC 3-2006</a>.</span></span></span></span></div></li></ul></li></ul></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">V.iii.1.B.3.b<a id=\"3b\" name=\"3b\">.</a>  Variations in Terminology for IVDS  </span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Variations of diagnostic terminology exist for IVDS.  When used in the clinical setting, the following terminology is consistent with the general designation of IVDS:</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">slipped or herniated disc</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">ruptured disc</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">prolapsed disc</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">bulging or protruded disc</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">DDD</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">sciatica</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">discogenic pain syndrome</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">herniated nucleus pulposus, and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">pinched nerve.</span></span></div></li></ul></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">V.iii.1.B.3.c<a id=\"3c\" name=\"3c\">.</a>  Definition:  Incapacitating Episode of IVDS</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">By definition, an incapacitating episode of IVDS requires bedrest prescribed by a physician. </span></span></div><div></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">When evaluating IVDS based on incapacitating episodes, there must be evidence the associated symptoms required bedrest as prescribed by a physician.  The medical evidence of prescribed bedrest must be</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">of record in the claims folder, <strong><em>or</em></strong></span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">reviewed and described by an examiner completing an examination or disability benefits questionnaire (DBQ).</span></span></div></li></ul><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><strong><em>Note</em></strong>:  If the records do not adequately document prescribed bedrest, use the General Rating Formula to evaluate IVDS and advise the Veteran to submit medical evidence documenting the periods of incapacitating episodes requiring bedrest prescribed by a physician.</span></span></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">V.iii.1.B.3.d<a id=\"3d\" name=\"3d\">.</a>  Objective Neurological Impairment Associated With Spinal Disabilities  </span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\">Objective neurological abnormalities associated with spinal disabilities </span></span></div><ul><li><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\">are evaluated separately from the spinal disability (<strong><em>except</em></strong>, as noted in <a href=\"#3a\" target=\"_self\">M21-1, Part V, Subpart iii, 1.B.3.a</a>, when IVDS is evaluated based on incapacitating episodes), and</span></span></div></li><li><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\">represent a medical progression or worsening of the spinal disease. </span></span></div><ul><li><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\">For that reason and because neurological complications of spinal disease are contemplated in the evaluation criteria for spinal conditions under <a href=\"https://www.ecfr.gov/current/title-38/section-4.71a\">38 CFR 4.71a</a>, a claim asserting new complications of spinal disease is considered a claim for increase rather than a claim for secondary SC.</span></span></div></li><li><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\">When evaluating an expressly claimed spinal disability, decision makers must consider entitlement to compensation for any neurological complications as within scope of the claim in accordance with <a articleid=\"554400000180486\" articlename=\"M21-1, Part V, Subpart ii, Chapter 3, Section A - Determining the Issues\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000180486/M21-1-Part-V-Subpart-ii-Chapter-3-Section-A-Determining-the-Issues\">M21-1, Part V, Subpart ii, 3.A.2.c</a>.</span></span></div></li><li><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\">Likewise, a primary spinal condition responsible for an expressly claimed neurological complication is considered within the scope of the expressly claimed issue, as discussed in <a articleid=\"554400000180486\" articlename=\"M21-1, Part V, Subpart ii, Chapter 3, Section A - Determining the Issues\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000180486/M21-1-Part-V-Subpart-ii-Chapter-3-Section-A-Determining-the-Issues\">M21-1, Part V, Subpart ii, 3.A.1.c</a>.</span></span></div></li><li><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\">When assigning effective dates for neurological spinal complications, consider effective date provisions specifically for increases as specified in <a articleid=\"554400000180492\" articlename=\"M21-1, Part V, Subpart ii, Chapter 4, Section A - Effective Dates\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000180492/M21-1-Part-V-Subpart-ii-Chapter-4-Section-A-Effective-Dates\"> M21-1, Part V, Subpart ii, 4.A.5.e</a>. </span></span></div></li></ul></li></ul><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\"><em><strong>Notes</strong></em>:  </span></span></div><ul><li><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\">When an SC thoracolumbar disability is present and objective neurological abnormalities or radiculopathy are diagnosed but the medical evidence does not identify a specific nerve root, rate the lower extremity radiculopathy under the sciatic nerve, <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=b563d2caeb25864bc9eba141a3d9f64e&amp;node=se38.1.4_1124a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.124a, DC 8520</a>.</span></span></div></li><li><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\">Additional examinations of other body systems may be required if there are neurological complications of the peripheral nerves, bladder, and/or impairment of sphincter control.  </span></span></div></li><li><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\">Apply the previous provisions of historical <a href=\"http://www.gpo.gov/fdsys/pkg/CFR-2009-title38-vol1/xml/CFR-2009-title38-vol1-sec3-157.xml\" target=\"_blank\">38 CFR 3.157(b)</a> when determining the effective date for neurological abnormalities of the spine that are identified by requisite records prior to March 24, 2015. </span></span></div></li></ul><div style=\"margin-left: 80px;\"><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\"><em><strong>Example</strong></em>:  Veteran has been SC for DDD since 2012.  Upon review of a claim for increase received on June 2, 2015, it is noted in Department of Veterans Affairs (VA) medical records that the Veteran received treatment for bladder impairment secondary to DDD on July 7, 2014.  Because the VA medical records constitute a claim for increase under rules in effect prior to March 24, 2015, it is permissible to apply previous rules from <a href=\"https://www.ecfr.gov/cgi-bin/text-idx?SID=1b780b2c30613fbf044bcf8e86b6fc85&amp;pitd=20150101&amp;node=se38.1.3_1157&amp;rgn=div8\" target=\"_blank\">38 CFR 3.157 (b)</a> in adjudicating the bladder impairment issue.</span></span></div><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\"> </span></span></div><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\"><strong><em>References</em></strong>:  For more information on </span></span></div><ul><li><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\">assigning disability evaluations for</span></span></div><ul><li><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\">peripheral nerve disabilities, to include radiculopathy, see <a articleid=\"554400000180519\" articlename=\"M21-1, Part V, Subpart iii, Chapter 12, Section A - Neurological Conditions and Convulsive Disorders\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000180519/M21-1-Part-V-Subpart-iii-Chapter-12-Section-A-Neurological-Conditions-and-Convulsive-Disorders\">M21-1, Part V, Subpart iii, 12.A.2</a>, and</span></span></div></li><li><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\">progressive spinal muscular atrophy, see <a articleid=\"554400000180519\" articlename=\"M21-1, Part V, Subpart iii, Chapter 12, Section A - Neurological Conditions and Convulsive Disorders\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000180519/M21-1-Part-V-Subpart-iii-Chapter-12-Section-A-Neurological-Conditions-and-Convulsive-Disorders\">M21-1, Part V, Subpart iii, 12.A.1.c</a></span></span></div></li></ul></li><li><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\">issues within the scope of a claim, see</span></span></div><ul><li><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\"><a href=\"https://www.ecfr.gov/on/2024-07-22/title-38/section-3.155\" target=\"_blank\">38 CFR 3.155(d)(2)</a>, and</span></span></div></li><li><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\"><a articleid=\"554400000180486\" articlename=\"M21-1, Part V, Subpart ii, Chapter 3, Section A - Determining the Issues\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000180486/M21-1-Part-V-Subpart-ii-Chapter-3-Section-A-Determining-the-Issues\">M21-1, Part V, Subpart ii, 3.A.2</a></span></span></div></li></ul></li><li><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\">assigning effective dates for neurological spinal complications, see</span></span></div><ul><li><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\"><a href=\"https://www.ecfr.gov/on/2024-08-20/title-38/section-3.400\" target=\"_blank\">38 CFR 3.400(o)</a></span></span></div></li><li><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\"><a href=\"https://www.ecfr.gov/current/title-38/section-3.155\" target=\"_blank\">38 CFR 3.155</a>, and</span></span></div></li><li><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\"><a articleid=\"554400000180492\" articlename=\"M21-1, Part V, Subpart ii, Chapter 4, Section A - Effective Dates\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000180492/M21-1-Part-V-Subpart-ii-Chapter-4-Section-A-Effective-Dates\">M21-1, Part V, Subpart ii, 4.A.1.g</a>, and</span></span></div></li></ul></li><li><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\">procedural guidance on handling the effective dates and coding complications of an SC disability in Veterans Benefits Management System - Rating (VBMS-R), see <a articleid=\"554400000180492\" articlename=\"M21-1, Part V, Subpart ii, Chapter 4, Section A - Effective Dates\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000180492/M21-1-Part-V-Subpart-ii-Chapter-4-Section-A-Effective-Dates\">M21-1, Part V, Subpart ii, 4.A.5.e</a>.</span></span></div></li></ul></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">V.iii.1.B.3.e<a id=\"3e\" name=\"3e\">.</a> Examples Addressing Neurological Impairments Associated With Spinal Disabilities</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; vertical-align: top; padding: 0px;\"><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\"><b><i>Example 1</i></b>:  A Veteran files a claim for an increased evaluation for the SC condition of spinal stenosis.  An intent to file (ITF) a claim was not received.  The DBQ shows decreased ROM of the spine that is unchanged from the prior evaluation and a diagnosis of radiculopathy of the bilateral lower extremities.  No other evidence indicates that radiculopathy was diagnosed prior to the date of this DBQ.  The rating activity should evaluate the spinal stenosis and grant SC for bilateral radiculopathy with an effective date assigned based on the receipt of the claim for the increased evaluation in the spinal stenosis.</span></span></div><div></div><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\"><b><i>Example 2</i></b>:  A Veteran submits a claim for SC of right leg pain and numbness, more than one year following discharge.  An ITF is not associated with this claim.  Development of the claim confirms a diagnosis of radiculopathy that is due to an unclaimed back injury.  The back injury was sustained in service.  Sufficient evidence to establish SC for the back disability is of record.  Consider the unclaimed back disability within scope of the claimed radiculopathy and establish SC for both issues with an effective date assigned based on the date of the receipt of the claim for SC of radiculopathy.</span></span></div><div></div><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\"><b><i>Example 3</i></b>:  The Veteran files a <i><a href=\"https://www.vba.va.gov/pubs/forms/VBA-21-526EZ-ARE.pdf\" target=\"_blank\">VA Form 21-526EZ, Application for Disability Compensation and Related Compensation Benefits</a></i>, for an increased evaluation in an SC spinal disability.  In conjunction with that claim, the Veteran submits private medical records showing a diagnosis of radiculopathy, related to the SC spinal disability, within the last year.  An ITF is not associated with the claim.  The private medical evidence is sufficient to evaluate the radiculopathy but does not contain ROM findings for the lumbosacral spine.  The rating activity should grant SC for radiculopathy from the date of the diagnosis of radiculopathy (in accordance with <a href=\"https://www.ecfr.gov/on/2024-08-22/title-38/section-3.400\" target=\"_blank\">38 CFR 3.400(o)(2)</a>) and defer the evaluation of the spinal disability for an increase evaluation examination.</span></span></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">V.iii.1.B.3.f<a id=\"3f\" name=\"3f\">.</a>  DBQ Selections for Radiculopathy</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; vertical-align: top; padding: 0px;\"><div><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">Radiculopathy is a common type of neurological impairment associated with spinal disabilities.</span></span></div><div></div><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">Refer to the table below to determine which DBQ to request when the claimed disability is a thoracolumbar/cervical spine condition and/or lumbar/cervical radiculopathy.</span></span></div></div><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"> </span></span></div><div><table border=\"1\" cellpadding=\"1\" cellspacing=\"1\" style=\"width: 510px; border-spacing: 1px; border-collapse: revert;\" summary=\"This is an If-Then table.  Column 1 provides the criteria and column 2 provides the DBQ to request.\" width=\"510\"><thead><tr><th scope=\"col\" style=\"width: 523px; vertical-align: top; padding: 1px;\"><div style=\"text-align: left\"><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><strong>If the claimed condition is a/an ...</strong></span></span></div></th><th scope=\"col\" style=\"width: 523px; vertical-align: top; padding: 1px;\"><div style=\"text-align: left\"><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><strong>Then, request the ...</strong></span></span></div></th></tr></thead><tbody><tr><td style=\"width: 523px; vertical-align: top; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">thoracolumbar spine condition (initial SC or increased evaluation) with or without a claim for radiculopathy</span></span></div></td><td style=\"width: 523px; vertical-align: top; padding: 1px;\"><div><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><i>Back (Thoracolumbar Spine) Conditions Disability Benefits Questionnaire </i>when otherwise necessary to decide the claim.</span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"> </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><b><i>Important</i></b>:</span></span></div><ul><li style=\"margin-left: 7.9pt\"><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">The DBQ contains a section for radiculopathy that must be completed by the examiner if there is an indication of radiculopathy.</span></span></div></li><li style=\"margin-left: 7.9pt\"><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><span style=\"color: black\">If the examiner fails to address radiculopathy, the examination must be returned as insufficient.</span></span></span></div></li></ul></div></td></tr><tr><td style=\"width: 523px; vertical-align: top; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">cervical spine condition (initial SC or increased evaluation) with or without a claim for radiculopathy</span></span></div></td><td style=\"width: 523px; vertical-align: top; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><i>Neck (Cervical Spine) Conditions Disability Benefits Questionnaire</i> when otherwise necessary to decide the claim.</span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"> </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><b><i>Important</i></b>:</span></span></div><ul><li style=\"margin-left: 7.9pt\"><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">The DBQ contains a section for radiculopathy that must be completed by the examiner if there is an indication of radiculopathy.</span></span></div></li><li style=\"margin-left: 7.9pt\"><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><span style=\"color: black\">If the examiner fails to address radiculopathy, the examination must be returned as insufficient.</span></span></span></div></li></ul></td></tr><tr><td style=\"width: 523px; vertical-align: top; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">increased evaluation of</span></span></div><ul><li style=\"margin-left: 7.9pt\"><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">lower extremity or lumbar radiculopathy, or</span></span></div></li><li style=\"margin-left: 7.9pt\"><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><span style=\"color: black\">upper extremity or cervical radiculopathy</span></span></span></div></li></ul></td><td style=\"width: 523px; vertical-align: top; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><i><span style=\"color: black\">Peripheral Nerves Conditions (Not Including Diabetic Sensory-Motor Peripheral Neuropathy) Disability Benefits Questionnaire.</span></i></span></span></div></td></tr><tr><td style=\"width: 523px; vertical-align: top; padding: 1px;\"><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\">upper extremity radiculopathy (initial SC) without a claim for cervical spine condition</span></span></div></td><td style=\"width: 523px; vertical-align: top; padding: 1px;\"><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\"><i>Neck (Cervical Spine) Disability Benefits Questionnaire</i></span></span></div><div></div><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\"><b><i>Important</i></b>:  If the examiner fails to address radiculopathy, the examination must be returned as insufficient.</span></span></div></td></tr><tr><td style=\"width: 523px; vertical-align: top; padding: 1px;\"><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\"><span style=\"color:black\">lower extremity radiculopathy (initial SC) without a claim for thoracolumbar spine condition</span></span></span></div></td><td style=\"width: 523px; vertical-align: top; padding: 1px;\"><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\"><i>Back (Thoracolumbar Spine) Conditions Disability Benefits Questionnaire</i></span></span></div><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\"><i> </i></span></span></div><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\"><b><i>Important</i></b>:  If the examiner fails to address radiculopathy, the examination must be returned as insufficient.</span></span></div></td></tr></tbody></table></div><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"> </span></span></div><div><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\"><em><strong>Note</strong></em>:  Do not routinely request an examination for an issue(s) for which the evidence of record is sufficient to make a decision.  This includes DBQs completed by a private or VA provider that are deemed adequate for rating purposes.</span></span></div><div></div><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\"><b><i>References</i></b>:  For more information on</span></span></div><ul><li style=\"margin-left: 7.9pt\"><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\">determining when an examination is necessary to decide a claim, see <a articleid=\"554400000180494\" articlename=\"M21-1, Part IV, Subpart i, Chapter 1, Section A - Duty to Assist With Providing a Medical Examination or Opinion\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000180494/M21-1-Part-IV-Subpart-i-Chapter-1-Section-A-Duty-to-Assist-With-Providing-a-Medical-Examination-or-Opinion\">M21-1, Part IV, Subpart i, 1.A</a></span></span></div></li><li style=\"margin-left: 7.9pt\"><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\">using medical evidence in lieu of an examination, see <a articleid=\"554400000180495\" articlename=\"M21-1, Part IV, Subpart i, Chapter 1, Section B - Evidentiary Standards for Finding an Examination or Opinion Necessary\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000180495/M21-1-Part-IV-Subpart-i-Chapter-1-Section-B-Evidentiary-Standards-for-Finding-an-Examination-or-Opinion-Necessary\">M21-1, Part IV, Subpart i, 1.B.1.a</a>, and</span></span></div></li><li style=\"margin-left: 7.9pt\"><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\">sufficiency of examinations, see <a articleid=\"554400000180514\" articlename=\"M21-1, Part IV, Subpart i, Chapter 3, Section A - General Criteria for Sufficiency of Examination Reports\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000180514/M21-1-Part-IV-Subpart-i-Chapter-3-Section-A-General-Criteria-for-Sufficiency-of-Examination-Reports\">M21-1, Part IV, Subpart i, 3.A</a>.</span></span></div></li></ul></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">V.iii.1.B.3.g<a id=\"3g\" name=\"3g\">.</a>  Example of Evaluating IVDS</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\"><strong><em>Situation</em></strong>:  A Veteran’s IVDS is being evaluated.</span></span></div><ul><li><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\">LOM warrants a 20-percent evaluation under the General Rating Formula for Diseases and Injuries of the Spine</span></span></div></li><li><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\">mild radiculopathy of the left lower extremity warrants a 10-percent evaluation as a neurological complication (evidence of irritation of the adjacent nerve root) under <a href=\"https://www.ecfr.gov/current/title-38/section-4.124a\">38 CFR 4.124a, DC 8520</a>, and</span></span></div></li><li><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\">medical evidence shows incapacitating episodes requiring bedrest prescribed by a physician of four weeks duration over the past 12 months which would result in a 40-percent evaluation based on the incapacitating episode formula.</span></span></div></li></ul><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\"><strong><em>Result</em></strong>:  Assign a 40-percent evaluation under <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=13bcad22732de2e24d3da7cad62932d5&amp;node=se38.1.4_171a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.71a, DC 5243</a> based on incapacitating episodes. </span></span></div><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\"> </span></span></div><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\"><strong><em>Explanation</em></strong>:</span></span></div><ul><li><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\">Evaluating IVDS using incapacitating episodes results in the highest evaluation.</span></span></div></li><li><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\">Since incapacitating episodes are used to evaluate IVDS, the associated LOM and neurological signs and symptoms will not be assigned a separate evaluation.</span></span></div></li></ul></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">V.iii.1.B.3.h<a id=\"3h\" name=\"3h\">.</a>  Evaluating Ankylosing Spondylitis</span></span></h3></td><td style=\"height: 8px; width: 15px; vertical-align: top; padding: 0px;\"></td><td style=\"width: 523px; vertical-align: top; padding: 0px;\"><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">Ankylosing spondylitis may be evaluated as an active disease process or based upon LOM of the spine. </span></span></div><div></div><div><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">The table below describes appropriate action for evaluating ankylosing spondylitis.</span></span></div><div></div><table border=\"1\" cellpadding=\"1\" cellspacing=\"1\" style=\"width: 510px; border-spacing: 1px; border-collapse: revert;\" summary=\"This is an If-Then table.  Column 1 provides the criteria and column 2 provides the actions for evaluating ankylosing spondylitis.\" width=\"510\"><thead><tr><th scope=\"col\" style=\"width: 523px; vertical-align: top; padding: 1px;\"><div style=\"text-align: left\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><strong>If ankylosing spondylitis is ...</strong></span></span></div></th><th scope=\"col\" style=\"width: 523px; vertical-align: top; padding: 1px;\"><div style=\"text-align: left\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><strong>Then ...</strong></span></span></div></th></tr></thead><tbody><tr><td style=\"width: 523px; vertical-align: top; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">an active process</span></span></div></td><td style=\"width: 523px; vertical-align: top; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">evaluate under <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=13bcad22732de2e24d3da7cad62932d5&amp;node=se38.1.4_171a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.71a, DC 5009</a>(using the criteria in <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=13bcad22732de2e24d3da7cad62932d5&amp;node=se38.1.4_171a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.71a, DC 5002</a> for the acute phase).</span></span></div></td></tr><tr><td style=\"width: 523px; vertical-align: top; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">inactive</span></span></div></td><td style=\"width: 523px; vertical-align: top; padding: 1px;\"><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">evaluate based on chronic residuals affecting the spine under <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=13bcad22732de2e24d3da7cad62932d5&amp;node=se38.1.4_171a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.71a, DC 5003 or DC 5240</a>, and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">separately evaluate other affected joints or body systems under the appropriate DC.</span></span></div></li></ul></td></tr></tbody></table><div></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><div class=\"ng-scope\" style=\"margin-left: 85pt\"></div><div class=\"ng-scope\"></div><div class=\"ng-scope\"><h2><span style=\"font-size: 16px\"><span style=\"font-family: arial, helvetica, sans-serif\">4<a id=\"4\" name=\"4\">.</a>  Evaluating Musculoskeletal Disabilities of the Legs</span></span></h2><p></p></div><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><strong>Introduction</strong></span></span></div></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">This topic contains information on evaluating musculoskeletal disabilities of the lower extremities (not including the feet), including </span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#4a\" target=\"_self\">evaluating noncompensable knee conditions</a></span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#4b\" target=\"_self\">definition of instability and subluxation of the knee</a></span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#4c\" target=\"_self\">evaluating instability of the knee</a></span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">separate evaluations </span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#4d\" target=\"_self\">for knee instability and LOM</a>, and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#4e\" target=\"_self\">of meniscal disabilities</a></span></span></div></li></ul></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#4f\" target=\"_self\">examples of evaluating meniscal disabilities</a></span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#4g\" target=\"_self\">separate evaluations – genu recurvatum</a></span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#4h\" target=\"_self\">conservative therapy for shin splints</a></span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#4i\" target=\"_self\">evaluating pain associated with shin splints</a></span></span><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">, and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#4j\" target=\"_self\">ankle instability</a>. </span></span></div></li></ul></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Change Date</span></span></div></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">April 25, 2022</span></span></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">V.iii.1.B.4.a<a id=\"4a\" name=\"4a\">.</a>  Evaluating Noncompensable Knee Conditions</span></span></h3></td><td style=\"height: 8px; width: 15px; vertical-align: top; padding: 0px;\"></td><td style=\"width: 522px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Evaluate a noncompensable knee condition by analogy to <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=70df8a154d2bdffaab9f94956057a637&amp;node=pt38.1.4&amp;rgn=div5#se38.1.4_171a\" target=\"_blank\">38 CFR 4.71a, DC 5257</a> if</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">there is no associated arthritis</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">the schedular criteria for a noncompensable evaluation under <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=70df8a154d2bdffaab9f94956057a637&amp;node=pt38.1.4&amp;rgn=div5#se38.1.4_171a\" target=\"_blank\">38 CFR 4.71a, DC 5260</a> or <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=70df8a154d2bdffaab9f94956057a637&amp;node=pt38.1.4&amp;rgn=div5#se38.1.4_171a\" target=\"_blank\">DC 5261</a> are not met, <em>and</em></span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">the condition cannot be appropriately evaluated under <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=70df8a154d2bdffaab9f94956057a637&amp;node=pt38.1.4&amp;rgn=div5#se38.1.4_171a\" target=\"_blank\">38 CFR 4.71a, DC 5258, 5259, 5262, or 5263</a>.</span></span></div></li></ul><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><strong><em>References</em></strong>:  For more information on</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">using analogous DCs, see <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=a25f6b8117934a9ebee262b5ec0a0a60&amp;mc=true&amp;node=se38.1.4_120&amp;rgn=div8\" target=\"_blank\">38 CFR 4.20</a>, and </span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">when to assign a 0-percent evaluation, see <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=7cfdb4f1b10584057cd96f9f5c031c61&amp;mc=true&amp;node=se38.1.4_131&amp;rgn=div8\" target=\"_blank\">38 CFR 4.31</a>.</span></span></div></li></ul></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">V.iii.1.B.4.b<a id=\"4b\" name=\"4b\">.</a>  Definitions:  Instability and Subluxation of the Knee</span></span></h3></td><td style=\"height: 9px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>Instability</em></strong>, as referred to in <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=0bd8cbf4ebf7f012b8415b710ea821da&amp;mc=true&amp;node=se38.1.4_171a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.71a, DC 5257</a>, includes </span></span></div><div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">patellar instability due to recurrent patellar subluxation or patellar dislocation, and/or</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">any other instability or laxity of the knee that involves other stabilizing structure of the knee such as the collateral or cruciate ligaments.</span></span></div></li></ul></div><div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>Subluxation </em></strong>refers to partial or incomplete dislocation of the knee joint (<em>tibiofemoral</em> dislocation/subluxation) or tendency for the patella to dislocate from its track (<em>patellar</em> dislocation/subluxation).  </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></div></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Evaluations under <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=0bd8cbf4ebf7f012b8415b710ea821da&amp;mc=true&amp;node=se38.1.4_171a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.71a, DC 5257</a> may be assigned based on the requirement for assistive device(s) and/or bracing.  The assistive device or bracing must be prescribed by a medical provider and there must be objective evidence of the prescription in the evidentiary record.  </span></span></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">V.iii.1.B.4.c<a id=\"4c\" name=\"4c\">.</a>  Evaluating Instability of the Knee</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">Evaluations for instability of the knee are assigned based on whether the instability arises from</span></span></div><ul><li><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">sprain or a ligament tear, or</span></span></li><li><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">patellar instability.</span></span></li></ul><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">When there is persistent instability but the medical evidence and/or examination report does not identify the instability as related to either a ligament tear/sprain or a diagnosed condition involving the patellofemoral complex (such as instability due to osteoarthritis or osteoarthrosis), then evaluate it using the patellar instability criteria under <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=0bd8cbf4ebf7f012b8415b710ea821da&amp;mc=true&amp;node=se38.1.4_171a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.71a, DC 5257</a>.</span></span></div><div></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><em><strong>Note</strong></em>:  The presence of persistent instability is sufficient to satisfy the requirement of recurrent symptoms for the 10-percent evaluation.</span></span></span></div></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">V.iii.1.B.4.d<a id=\"4d\" name=\"4d\">.</a>  Separate Evaluations for Knee Instability and LOM</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">A separate evaluation for knee instability may be assigned in addition to any evaluation(s) assigned based on limitation of knee motion.  The Office of General Counsel has issued precedent opinions that an evaluation under <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=70df8a154d2bdffaab9f94956057a637&amp;node=pt38.1.4&amp;rgn=div5#se38.1.4_171a\" target=\"_blank\">38 CFR 4.71a, DC 5257</a>, does not pyramid with evaluations based on LOM.  </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">  </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>References</em></strong>:  For more information on</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">pyramiding and separating individual findings in a rating decision, see <a articleid=\"554400000180489\" articlename=\"M21-1, Part V, Subpart ii, Chapter 3, Section D - Evaluating Disabilities\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000180489/M21-1-Part-V-Subpart-ii-Chapter-3-Section-D-Evaluating-Disabilities\">M21-1, Part V, Subpart ii, 3.D.2.b</a></span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">separate evaluation of knee instability, see</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a articleid=\"554400000043704\" articlename=\"VAOPGCPREC 23-97, Jul 1, 1997, Multiple Ratings for Knee Disability\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000043704/VAOPGCPREC-23-97-Jul-1-1997-Multiple-Ratings-for-Knee-Disability\">VAOPGCPREC 23-1997</a>, and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a articleid=\"554400000043745\" articlename=\"VAOPGCPREC 09-98, Aug 14, 1998, Multiple Ratings for Musculoskeletal Disability and Applicability of 38 CFR §§ 4.40, 4.45, and 4.59\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000043745/VAOPGCPREC-09-98-Aug-14-1998-Multiple-Ratings-for-Musculoskeletal-Disability-and-Applicability-of-38-CFR-440-445-and-459\">VAOPGCPREC 9-1998</a>, and</span></span></div></li></ul></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">evaluation of joint replacement or resurfacing, see <a articleid=\"554400000014407\" articlename=\"M21-1, Part V, Subpart iii, Chapter 1, Section A - Painful Motion and Functional Loss\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000014407/M21-1-Part-V-Subpart-iii-Chapter-1-Section-A-Painful-Motion-and-Functional-Loss\">M21-1, Part V, Subpart iii, 1.A.3.h-j</a>.</span></span></div></li></ul></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">V.iii.1.B.4.e<a id=\"4e\" name=\"4e\">.</a>  Separate Evaluation of Meniscal Disabilities</span></span></h3></td><td style=\"height: 8px; width: 15px; vertical-align: top; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Evaluation of a knee disability under <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=0bd8cbf4ebf7f012b8415b710ea821da&amp;mc=true&amp;node=se38.1.4_171a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.71a, DC 5257, DC 5260</a>, or <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=0bd8cbf4ebf7f012b8415b710ea821da&amp;mc=true&amp;node=se38.1.4_171a&amp;rgn=div8\" target=\"_blank\">5261</a> does not, as a matter of law, preclude separate evaluation of a meniscal disability of the same knee under<span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=0bd8cbf4ebf7f012b8415b710ea821da&amp;mc=true&amp;node=se38.1.4_171a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.71a, DC 5258</a> (dislocated semilunar cartilage), or</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=0bd8cbf4ebf7f012b8415b710ea821da&amp;mc=true&amp;node=se38.1.4_171a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.71a, DC 5259</a> (symptomatic removal of semilunar cartilage).</span></span></div></li></ul><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">A meniscal disability may be rated separately under <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=0bd8cbf4ebf7f012b8415b710ea821da&amp;mc=true&amp;node=se38.1.4_171a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.71a, DC 5258/5259</a> apart from<span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=0bd8cbf4ebf7f012b8415b710ea821da&amp;mc=true&amp;node=se38.1.4_171a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.71a, DC 5257</a> for manifestations of the knee disability other than recurrent subluxation and instability, and/or</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=0bd8cbf4ebf7f012b8415b710ea821da&amp;mc=true&amp;node=se38.1.4_171a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.71a, DC 5260/5261</a> if a manifestation of the meniscal disability did not result in an elevation of the disability evaluation warranted  under <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=0bd8cbf4ebf7f012b8415b710ea821da&amp;mc=true&amp;node=se38.1.4_171a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.71a, DC 5260/5261</a> via application of <a href=\"https://www.ecfr.gov/cgi-bin/text-idx?SID=b666bbcef57d8aca78c2a5cb028975bb&amp;mc=true&amp;node=se38.1.4_140&amp;rgn=div8\" target=\"_blank\">38 CFR 4.40</a> and <a href=\"https://www.ecfr.gov/cgi-bin/text-idx?SID=b666bbcef57d8aca78c2a5cb028975bb&amp;mc=true&amp;node=se38.1.4_145&amp;rgn=div8\" target=\"_blank\">38 CFR 4.45</a> pursuant to </span></span><a articleid=\"554400000070971\" articlename=\"DeLuca v. Brown, Sep 22, 1995, 8 Vet.App. 202 (1995)\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000070971/DeLuca-v-Brown-Sep-22-1995-8-VetApp-202-1995\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><em>DeLuca v. Brown</em></span></span></a><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">, 8 Vet.App. 202 (1995). </span></span></div></li></ul><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>Important</em></strong>: </span></span></span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">A repaired meniscal tear (s/p partial meniscectomy) is not directly synonymous with either <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=0bd8cbf4ebf7f012b8415b710ea821da&amp;mc=true&amp;node=se38.1.4_171a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.71a, DC 5258</a> or <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=0bd8cbf4ebf7f012b8415b710ea821da&amp;mc=true&amp;node=se38.1.4_171a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.71a, DC 5259</a>.  Therefore, it is most appropriate to rate the disability analogous to whichever code most closely approximates the current symptoms.</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Entitlement to a separate evaluation for the meniscal disability depends on whether the manifestations are utilized to assign an evaluation under a different DC.  Evaluation of the same manifestation under multiple diagnoses is prohibited under <a href=\"https://www.ecfr.gov/cgi-bin/text-idx?SID=5b5a1f4fd2d936fa785c43b86106f080&amp;mc=true&amp;node=se38.1.4_114&amp;rgn=div8\" target=\"_blank\">38 CFR 4.14</a>.  Thus, when all the symptoms of the meniscal disability are used to support elevation of an evaluation under <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=0bd8cbf4ebf7f012b8415b710ea821da&amp;mc=true&amp;node=se38.1.4_171a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.71a, DC 5260/5261</a> or assignment of an evaluation under <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=0bd8cbf4ebf7f012b8415b710ea821da&amp;mc=true&amp;node=se38.1.4_171a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.71a, DC 5257</a>, a separate evaluation cannot be assigned under <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=0bd8cbf4ebf7f012b8415b710ea821da&amp;mc=true&amp;node=se38.1.4_171a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.71a, DC 5258/5259</a>.</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">When considering applicability of <a href=\"https://www.ecfr.gov/cgi-bin/text-idx?SID=70df8a154d2bdffaab9f94956057a637&amp;node=se38.1.4_159&amp;rgn=div8\" target=\"_blank\">38 CFR 4.59</a> for meniscal disabilities,</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">when <em>only</em> a meniscal disability is present, utilize the procedures at <a articleid=\"554400000014407\" articlename=\"M21-1, Part V, Subpart iii, Chapter 1, Section A - Painful Motion and Functional Loss\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000014407/M21-1-Part-V-Subpart-iii-Chapter-1-Section-A-Painful-Motion-and-Functional-Loss\">M21-1, Part V, Subpart iii, 1.A.1.m</a>, and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">when multiple knee disabilities are present and the painful motion is attributable to a knee disability other than the meniscal condition, assign separate evaluations when otherwise warranted under <a href=\"https://www.ecfr.gov/cgi-bin/text-idx?SID=70df8a154d2bdffaab9f94956057a637&amp;node=se38.1.4_114&amp;rgn=div8\" target=\"_blank\">38 CFR 4.14</a>.</span></span></div></li></ul></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">The policy and procedures identified in this block reflect a change in policy resulting from the holding in <a articleid=\"554400000083408\" articlename=\"Lyles v. Shulkin, Nov 29, 2017, 29 Vet.App. 107 (2017)\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000083408/Lyles-v-Shulkin-Nov-29-2017-29-VetApp-107-2017\"><em>Lyles v. Shulkin</em></a>, 29 Vet.App. 107 (2017), effective November 29, 2017.  Prior to the <em>Lyles</em> holding, separate evaluations for meniscal disabilities under <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=0bd8cbf4ebf7f012b8415b710ea821da&amp;mc=true&amp;node=se38.1.4_171a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.71a, DC 5258</a> or <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=0bd8cbf4ebf7f012b8415b710ea821da&amp;mc=true&amp;node=se38.1.4_171a&amp;rgn=div8\" target=\"_blank\">DC 5259</a> and other knee evaluations under <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=0bd8cbf4ebf7f012b8415b710ea821da&amp;mc=true&amp;node=se38.1.4_171a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.71a, DC 5257, 5260, or DC 5261</a> were prohibited.  This is not considered a liberalizing change.</span></span></div></li></ul><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>References</em></strong>:  For more information on</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">evaluation of meniscal disabilities, see <a articleid=\"554400000083408\" articlename=\"Lyles v. Shulkin, Nov 29, 2017, 29 Vet.App. 107 (2017)\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000083408/Lyles-v-Shulkin-Nov-29-2017-29-VetApp-107-2017\"><em>Lyles v. Shulkin</em></a>, 29 Vet.App. 107 (2017), and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">examples of evaluation of meniscal disabilities, see <a href=\"#4f\" target=\"_self\">M21-1, Part V, Subpart iii, 1.B.4.f</a></span></span><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">.</span></span></div></li></ul></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">V.iii.1.B.4.f<a id=\"4f\" name=\"4f\">.</a>  Examples-- Evaluating Meniscal Disabilities</span></span></h3></td><td style=\"height: 8px; width: 15px; vertical-align: top; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>Example 1</em></strong>:  A Veteran’s left knee disability, which includes a meniscal condition, is evaluated as 30-percent disabling on the basis of limitation of extension under <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=0bd8cbf4ebf7f012b8415b710ea821da&amp;mc=true&amp;node=se38.1.4_171a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.71a, DC 5261</a>.  The knee also manifests pain, swelling, popping, locking, and grinding due to the meniscus disability.  These symptoms, which are consistent with the manifestations identified under <a href=\"https://www.ecfr.gov/cgi-bin/text-idx?SID=b666bbcef57d8aca78c2a5cb028975bb&amp;mc=true&amp;node=se38.1.4_140&amp;rgn=div8\" target=\"_blank\">38 CFR 4.40</a> and <a href=\"https://www.ecfr.gov/cgi-bin/text-idx?SID=b666bbcef57d8aca78c2a5cb028975bb&amp;mc=true&amp;node=se38.1.4_145&amp;rgn=div8\" target=\"_blank\">38 CFR 4.45</a>, were considered and did not result in a higher evaluation under <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=0bd8cbf4ebf7f012b8415b710ea821da&amp;mc=true&amp;node=se38.1.4_171a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.71a, DC 5261</a>.  Therefore, they may be considered for assignment of a separate evaluation under <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=0bd8cbf4ebf7f012b8415b710ea821da&amp;mc=true&amp;node=se38.1.4_171a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.71a, DC 5258/5259</a>.</span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>Example 2</em></strong>:  The evaluations and fact pattern for Example 1 are the same <em>except </em>that the VA examiner indicates that the pain, swelling, popping, locking, and grinding of the knee, which results from the meniscal disability, result in additional limitation of extension to 30 degrees during flare-ups or with repeated use over a period of time, which warrants an elevation of the rating to 40-percent under <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=0bd8cbf4ebf7f012b8415b710ea821da&amp;mc=true&amp;node=se38.1.4_171a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.71a, DC 5261</a>.  A separate evaluation under <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=0bd8cbf4ebf7f012b8415b710ea821da&amp;mc=true&amp;node=se38.1.4_171a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.71a, DC 5258/5259</a> is not warranted for the symptoms of pain, swelling, popping, locking, and grinding since these symptoms were considered under <a href=\"https://www.ecfr.gov/cgi-bin/text-idx?SID=b666bbcef57d8aca78c2a5cb028975bb&amp;mc=true&amp;node=se38.1.4_140&amp;rgn=div8\" target=\"_blank\">38 CFR 4.40</a> and <a href=\"https://www.ecfr.gov/cgi-bin/text-idx?SID=b666bbcef57d8aca78c2a5cb028975bb&amp;mc=true&amp;node=se38.1.4_145&amp;rgn=div8\" target=\"_blank\">38 CFR 4.45</a> in accordance with the <em>DeLuca</em> holding to elevate the evaluation to 40-percent under <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=0bd8cbf4ebf7f012b8415b710ea821da&amp;mc=true&amp;node=se38.1.4_171a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.71a, DC 5261</a>.  Assignment of a separate evaluation under <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=0bd8cbf4ebf7f012b8415b710ea821da&amp;mc=true&amp;node=se38.1.4_171a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.71a, DC 5258/5259</a> would constitute pyramiding.</span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>Example 3</em></strong>:  A Veteran’s left knee disability, which includes meniscal impairment, is evaluated as 30-percent disabling on the basis of limitation of extension under <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=0bd8cbf4ebf7f012b8415b710ea821da&amp;mc=true&amp;node=se38.1.4_171a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.71a, DC 5261</a>.  Pain is present due to the meniscus disability.  A VA examiner indicated that pain during repetitive motion testing as well as functional loss due to pain during flare-ups additionally limit extension to 30 degrees, which results in elevation of the 30-percent evaluation under <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=0bd8cbf4ebf7f012b8415b710ea821da&amp;mc=true&amp;node=se38.1.4_171a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.71a, DC 5261</a> to 40-percent.  A separate evaluation under <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=0bd8cbf4ebf7f012b8415b710ea821da&amp;mc=true&amp;node=se38.1.4_171a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.71a, DC 5258/5259</a> is not warranted for the symptoms of pain since it was considered under <a href=\"https://www.ecfr.gov/cgi-bin/text-idx?SID=b666bbcef57d8aca78c2a5cb028975bb&amp;mc=true&amp;node=se38.1.4_140&amp;rgn=div8\" target=\"_blank\">38 CFR 4.40</a> and <a href=\"https://www.ecfr.gov/cgi-bin/text-idx?SID=b666bbcef57d8aca78c2a5cb028975bb&amp;mc=true&amp;node=se38.1.4_145&amp;rgn=div8\" target=\"_blank\">38 CFR 4.45</a> in accordance with the <em>DeLuca</em> holding to elevate the evaluation to 40-percent under <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=0bd8cbf4ebf7f012b8415b710ea821da&amp;mc=true&amp;node=se38.1.4_171a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.71a, DC 5261</a>.  Assignment of a separate evaluation under <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=0bd8cbf4ebf7f012b8415b710ea821da&amp;mc=true&amp;node=se38.1.4_171a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.71a, DC 5258/5259</a> would constitute pyramiding.</span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>Example 4</em></strong>:  A Veteran’s right knee disability is evaluated as 20-percent disabling on the basis of limitation of extension.  This disability includes arthritis of the joint and a post-operative meniscal condition.  The knee also manifests pain, swelling, popping, locking, and grinding due to both arthritis and the meniscal condition.  A VA examiner found that repetitive motion testing additionally limited extension by five degrees, from 15 to 20 degrees, due to pain.  The consideration of pain on motion, which is a manifestation identified under <a href=\"https://www.ecfr.gov/cgi-bin/text-idx?SID=b666bbcef57d8aca78c2a5cb028975bb&amp;mc=true&amp;node=se38.1.4_140&amp;rgn=div8\" target=\"_blank\">38 CFR 4.40</a> and <a href=\"https://www.ecfr.gov/cgi-bin/text-idx?SID=b666bbcef57d8aca78c2a5cb028975bb&amp;mc=true&amp;node=se38.1.4_145&amp;rgn=div8\" target=\"_blank\">38 CFR 4.45</a>, results in elevation of the evaluation under <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=0bd8cbf4ebf7f012b8415b710ea821da&amp;mc=true&amp;node=se38.1.4_171a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.71a, DC 5261</a> to 30-percent.  Since the swelling, popping, locking, and grinding, which were at least in part due to the meniscal condition, were not considered in awarding a higher evaluation under <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=0bd8cbf4ebf7f012b8415b710ea821da&amp;mc=true&amp;node=se38.1.4_171a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.71a, DC 5261</a> with application of <a href=\"https://www.ecfr.gov/cgi-bin/text-idx?SID=b666bbcef57d8aca78c2a5cb028975bb&amp;mc=true&amp;node=se38.1.4_140&amp;rgn=div8\" target=\"_blank\">38 CFR 4.40</a> and <a href=\"https://www.ecfr.gov/cgi-bin/text-idx?SID=b666bbcef57d8aca78c2a5cb028975bb&amp;mc=true&amp;node=se38.1.4_145&amp;rgn=div8\" target=\"_blank\">38 CFR 4.45</a>, a separate evaluation may be awarded for the meniscus removal. </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>Example 5</em></strong>:  Examination of the left knee disability reveals an unrepaired incomplete ligament tear that results in persistent instability.  The Veteran’s physician has prescribed a brace and a cane for ambulation.  Additionally, the Veteran has a history of meniscectomy with residual symptoms of stiffness, crepitus, and pain without effusion or locking.  ROM is full with no additional functional impairment following repeated ROM testing.  Since the stiffness, crepitus, and pain are separate symptoms and not used to support an evaluation under <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=0bd8cbf4ebf7f012b8415b710ea821da&amp;mc=true&amp;node=se38.1.4_171a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.71a, DC 5257/5260/5261</a> and the persistent instability is not used to support an evaluation for the meniscal symptoms, a 20-percent evaluation is warranted under <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=0bd8cbf4ebf7f012b8415b710ea821da&amp;mc=true&amp;node=se38.1.4_171a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.71a, DC 5257</a> with a separate 10-percent evaluation assigned under <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=0bd8cbf4ebf7f012b8415b710ea821da&amp;mc=true&amp;node=se38.1.4_171a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.71a, DC 5259</a>.</span></span></div></div><div></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">V.iii.1.B.4.g<a id=\"4g\" name=\"4g\">.</a>  Separate Evaluations – Genu Recurvatum</span></span></h3></td><td style=\"height: 8px; width: 15px; vertical-align: top; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">When evaluating genu recurvatum, which involves hyperextension of the knee beyond 0 degrees of extension, under <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=0bd8cbf4ebf7f012b8415b710ea821da&amp;mc=true&amp;node=se38.1.4_171a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.71a, DC 5263</a></span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">do <em>not also</em> evaluate separately under <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=0bd8cbf4ebf7f012b8415b710ea821da&amp;mc=true&amp;node=se38.1.4_171a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.71a, DC 5261</a>, but</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><em>do </em>evaluate separately under other evaluations <em>if</em> manifestations that are not overlapping, such as limitation of flexion under <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=0bd8cbf4ebf7f012b8415b710ea821da&amp;mc=true&amp;node=se38.1.4_171a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.71a, DC 5260</a>, are attributed to genu recurvatum, and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">do <em>not</em> evaluate separately under <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=0bd8cbf4ebf7f012b8415b710ea821da&amp;mc=true&amp;node=se38.1.4_171a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.71a, DC 5257</a>; however, if instability is manifested from genu recurvatum evaluate based on the criteria that will provide the highest evaluation.</span></span></div></li></ul></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">V.iii.1.B.4.h<a id=\"4h\" name=\"4h\">.</a>  Conservative Therapy for Shin Splints</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; vertical-align: top; padding: 0px;\"><div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Utilize <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=e8fdbb668d97e82f2406bf2c4a1bc49f&amp;node=se38.1.4_171a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.71a, DC 5262</a> for evaluating impairment of the tibia and fibula including nonunion, malunion (evaluated under the corresponding knee or ankle codes based on associated impairment), or medial tibial stress syndrome (MTSS).</span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Evaluations for MTSS may be based on the use of conservative treatment.  For this purpose, conservative treatment includes but is not limited to treatment of symptoms using the following:</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">rest</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">ice</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">elevation</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">medication</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">compression socks, and/or</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">massage.</span></span></div></li></ul><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>Note</em></strong>:  MTSS is synonymous with shin splints.  Related assessments, such as compartment syndrome and/or stress fractures, may also appear in treatment records.  When compartment syndrome is the predominant diagnosis, however, a rating under <a href=\"https://www.ecfr.gov/cgi-bin/text-idx?SID=03c3db765ef22fc0b2754142e5591059&amp;mc=true&amp;node=se38.1.4_173&amp;rgn=div8\" target=\"_blank\">38 CFR 4.73, DC 5331</a> is warranted.</span></span></div></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">V.iii.1.B.4.i<a id=\"4i\" name=\"4i\">.</a>  <strong>Evaluating Pain Associated With Shin Splints</strong></span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">MTSS, or shin splints, is a type of  joint or periarticular pathology which is a requirement for application of <a href=\"https://www.ecfr.gov/cgi-bin/text-idx?SID=723bf010a2bbd949375ecb0617db622e&amp;mc=true&amp;node=se38.1.4_159&amp;rgn=div8\" target=\"_blank\">38 CFR 4.59</a>, for assignment of the minimum compensable evaluation under <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=e8fdbb668d97e82f2406bf2c4a1bc49f&amp;node=se38.1.4_171a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.71a, DC 5262</a> when painful motion is shown and shin splints are otherwise noncompensable.  The following principles apply:</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Shin splints with pain that is not associated with motion, such as pain on palpation, are noncompensable under <a href=\"https://www.ecfr.gov/cgi-bin/text-idx?SID=723bf010a2bbd949375ecb0617db622e&amp;mc=true&amp;node=se38.1.4_159&amp;rgn=div8\" target=\"_blank\">38 CFR 4.59</a>.</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">The minimum compensable evaluation is warranted when painful motion due to shin splints occurs in nearby affected joints such as the ankle or knee or when shin pain or other similar pain occurs with motion.  However, when a separate knee or ankle disability exists and has been compensably evaluated, do not assign a compensable evaluation under <a href=\"https://www.ecfr.gov/cgi-bin/text-idx?SID=723bf010a2bbd949375ecb0617db622e&amp;mc=true&amp;node=se38.1.4_159&amp;rgn=div8\" target=\"_blank\">38 CFR 4.59</a> for shin splints causing painful motion in an already-compensable SC knee or ankle joint.</span></span></div></li></ul><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>Reference</em></strong>:  For more information on the applicability of <a href=\"https://www.ecfr.gov/cgi-bin/text-idx?SID=723bf010a2bbd949375ecb0617db622e&amp;mc=true&amp;node=se38.1.4_159&amp;rgn=div8\" target=\"_blank\">38 CFR 4.59</a> to ratings for shin splints, see</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a articleid=\"554400000014407\" articlename=\"M21-1, Part V, Subpart iii, Chapter 1, Section A - Painful Motion and Functional Loss\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000014407/M21-1-Part-V-Subpart-iii-Chapter-1-Section-A-Painful-Motion-and-Functional-Loss\">M21-1, Part V, Subpart iii, 1.A.1.i</a>, and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><em><a articleid=\"554400000056859\" articlename=\"Southall-Norman v. McDonald, Dec 15, 2016, 28 Vet.App. 346 (2016)\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000056859/Southall-Norman-v-McDonald-Dec-15-2016-28-VetApp-346-2016\">Southall-Norman v. McDonald</a></em>, 28 Vet.App. 346 (2016).  </span></span></div></li></ul></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">V.iii.1.B.4.j<a id=\"4j\" name=\"4j\">.</a> Ankle Instability</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Do not assign separate evaluations for LOM and instability of the ankle.</span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">The intent of the ankle DCs, including <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=2375abdd93d9ea77dbeab85b13dc534b&amp;node=se38.1.4_171a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.71a, DC 5271</a>, is to address the overall ankle disability without limiting the focus to one specific type of ankle symptomatology.</span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Although <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=2375abdd93d9ea77dbeab85b13dc534b&amp;node=se38.1.4_171a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.71a, DC 5271</a> is titled, <em>Ankle, limited motion of</em> and utilizes objective ROM measurements to guide the decision maker as to the meaning of marked and moderate in evaluating symptoms, this DC may also be used to rate instability of the ankle with or without associated LOM.  </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>Note</em></strong>:  <a href=\"https://www.ecfr.gov/cgi-bin/text-idx?SID=2375abdd93d9ea77dbeab85b13dc534b&amp;node=se38.1.4_120&amp;rgn=div8\" target=\"_blank\">38 CFR 4.20</a> provides that when a condition is not listed in the rating schedule, an analogous rating is to be assigned.  Based on the facts found, the DC most appropriate to the findings and that results in the highest evaluation should be selected.</span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>Reference</em></strong>:   For more information on analogous ratings, see</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a articleid=\"554400000180489\" articlename=\"M21-1, Part V, Subpart ii, Chapter 3, Section D - Evaluating Disabilities\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000180489/M21-1-Part-V-Subpart-ii-Chapter-3-Section-D-Evaluating-Disabilities\">M21-1, Part V, Subpart ii, 3.D.1.c</a>, and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a articleid=\"554400000180525\" articlename=\"M21-1, Part V, Subpart iv, Chapter 1, Section C - Coded Conclusion\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000180525/M21-1-Part-V-Subpart-iv-Chapter-1-Section-C-Coded-Conclusion\">M21-1, Part V, Subpart iv, 1.C.2.a and b</a>.</span></span></div></li></ul></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><div class=\"ng-scope\" style=\"margin-left: 85pt\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"> </span></span></div><div class=\"ng-scope\" style=\"margin-left: 85pt\"></div><div class=\"ng-scope\"><h2><span style=\"font-size: 16px\"><span style=\"font-family: arial, helvetica, sans-serif\">5<a id=\"5\" name=\"5\">.</a>  Evaluating Musculoskeletal Disabilities of the Feet</span></span></h2></div><div class=\"ng-scope\"></div><div class=\"ng-scope\"></div><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><strong>Introduction</strong></span></span></div></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">This topic contains information on evaluating musculoskeletal disabilities of the feet, including<span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></span></span></div><ul><li><div><a href=\"#5a\" target=\"_self\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">selecting a DC for foot disabilities</span></span></a></div></li><li><div><a href=\"#5b\" target=\"_self\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">identifying the digits of the foot</span></span></a></div></li><li><div><a href=\"#5c\" target=\"_self\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">assigning separate evaluations for multiple foot disabilities</span></span></a></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">evaluating </span></span></div><ul><li><div><a href=\"#5d\" target=\"_self\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">arthritis of the minor joints of the toes</span></span></a><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">, and</span></span></div></li><li><div><a href=\"#5e\" target=\"_self\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">plantar fasciitis</span></span></a></div></li></ul></li><li><div><a href=\"#5f\" target=\"_self\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">definition of metatarsalgia or Morton’s disease</span></span></a><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">, and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">evaluating </span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#5g\" target=\"_self\">metatarsalgia or Morton’s disease</a>, and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">metatarsalgia and</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#5h\" target=\"_self\">plantar fasciitis</a>, and</span></span></div></li><li><div><a href=\"#5i\" target=\"_self\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">pes planus</span></span></a><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">. </span></span></div></li></ul></li></ul></li></ul></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><strong>Change Date</strong></span></span></div></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">February 8, 2021</span></span></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">V.iii.1.B.5.a<a id=\"5a\" name=\"5a\">.</a>  Selecting a DC for Foot Disabilities</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Foot injuries are rated under <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=2ec7350adee36049b3011df9cfd38f55&amp;node=se38.1.4_171a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.71a, DC 5284</a>.  The application of this DC is limited to disabilities resulting from actual injuries to the foot, as opposed to disabilities caused by, for example, degenerative conditions.  However, conditions that are not specifically listed under <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=2ec7350adee36049b3011df9cfd38f55&amp;node=se38.1.4_171a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.71a, DC 5284</a> may be rated by analogy under DC 5284.</span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=2ec7350adee36049b3011df9cfd38f55&amp;node=se38.1.4_171a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.71a, DC 5284</a> does not apply to the other conditions of the foot specifically listed under <a href=\"https://www.ecfr.gov/cgi-bin/text-idx?SID=dcc466c3e069a06e73c46e3cc158e2b8&amp;mc=true&amp;node=se38.1.4_171a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.71a, DCs 5276 through 5283 and 5269</a>.  The listed conditions must be rated under the specified DCs and cannot be rated by analogy under <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=2ec7350adee36049b3011df9cfd38f55&amp;node=se38.1.4_171a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.71a, DC 5284</a>.</span></span></div><div></div></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">In cases where a foot injury <em>and</em> either arthritis or another foot disability is involved</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">consider functional impairment, and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">determine whether, depending on the nature of the disability and history of injury, it is more advantageous to evaluate the condition under <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=2ec7350adee36049b3011df9cfd38f55&amp;node=se38.1.4_171a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.71a, DC 5284</a> or another DC.</span></span></span></span></div></li></ul><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>Reminder</em></strong>:  Consider the guidance in <a articleid=\"554400000180525\" articlename=\"M21-1, Part V, Subpart iv, Chapter 1, Section C - Coded Conclusion\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000180525/M21-1-Part-V-Subpart-iv-Chapter-1-Section-C-Coded-Conclusion\">M21-1, Part V, Subpart iv, 1.C.4.b</a> concerning applicability of the bilateral factor when a DC provides one evaluation for a bilateral condition.</span></span></div><div></div><div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>References</em></strong>:  For more information on</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">limited applicability of <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=2ec7350adee36049b3011df9cfd38f55&amp;node=se38.1.4_171a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.71a, DC 5284</a> to foot injuries, see <a articleid=\"554400000056914\" articlename=\"Yancy v. McDonald, Feb 26, 2016, 27 Vet.App. 484 (2016)\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000056914/Yancy-v-McDonald-Feb-26-2016-27-VetApp-484-2016\"><em>Yancy v. McDonald</em></a>, 27 Vet.App. 484 (2016)</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">prohibition of evaluating specific foot disabilities otherwise listed in <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=2ec7350adee36049b3011df9cfd38f55&amp;node=se38.1.4_171a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.71a</a> analogously under <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=2ec7350adee36049b3011df9cfd38f55&amp;node=se38.1.4_171a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.71a, DC 5284</a>, see <a articleid=\"554400000056856\" articlename=\"Copeland v. McDonald, Jun 25, 2015, 27 Vet.App. 333 (2015)\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000056856/Copeland-v-McDonald-Jun-25-2015-27-VetApp-333-2015\"><em>Copeland v. McDonald</em></a>, 27 Vet.App. 333 (2015)</span></span>, and</div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">applying <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=ff07c75cd57bc7c5816feafc92fa44e0&amp;node=se38.1.4_159&amp;rgn=div8\" target=\"_blank\">38 CFR 4.59</a> to disabilities of minor joints, see <a articleid=\"554400000014407\" articlename=\"M21-1, Part V, Subpart iii, Chapter 1, Section A - Painful Motion and Functional Loss\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000014407/M21-1-Part-V-Subpart-iii-Chapter-1-Section-A-Painful-Motion-and-Functional-Loss\">M21-1, Part V, Subpart iii, 1.A.1.l</a>.</span></span></div></li></ul></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">V.iii.1.B.5.b<a id=\"5b\" name=\"5b\">.</a>  Identifying the Digits of the Foot</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Follow the guidelines listed below to accurately specify the injured digits of the foot.</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Refer to the digits of the foot as</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">first or great toe</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">second</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">third</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">fourth, or</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">fifth.</span></span></div></li></ul></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Each digit, except the great toe, includes three phalanges</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">the proximal phalanx (closest to the ankle)</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">the middle phalanx, and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">the distal phalanx (closest to the tip of the toe).</span></span></div></li></ul></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">The joint between the proximal and middle phalanges is called the <em><strong>proximal  interphalangeal</strong></em> (PIP) joint.</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">The joint between the middle and distal phalanges is called the <em><strong>distal interphalangeal</strong></em> (DIP) joint. </span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">The great toes each have only two phalanges, the proximal phalanx and the distal phalanx.  Therefore, each great toe has only a single joint, called the <em><strong>interphalangeal</strong></em> (IP) joint.</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">The joints connecting the phalanges in the feet to the metatarsals are the <em><strong>metatarsophalangeal</strong></em> (MTP) joints.</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Designate either right or left for the digits of the foot.</span></span></div></li></ul><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><strong><em>Note</em></strong>:  If the location of the injury is unclear, obtain x-rays to clarify the exact point of injury.</span></span></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">V.iii.1.B.5.c<a id=\"5c\" name=\"5c\">.</a>  Assigning Separate Evaluations for Multiple Foot Disabilities</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"https://www.ecfr.gov/cgi-bin/text-idx?SID=019403379b9d4d1c9aae93e88d236cae&amp;mc=true&amp;node=se38.1.4_114&amp;rgn=div8\" target=\"_blank\">38 CFR 4.14</a> requires that the evaluation of the same disability and/or the same manifestation under various diagnoses is to be avoided.</span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">The compact anatomical structure of the foot as well as the inter-related physiological functioning may make it difficult to differentiate the etiology of certain disability symptoms.  When multiple SC foot disabilities are present but the etiology of the symptoms cannot be separated, assign a single disability evaluation for the predominant symptoms. </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">If, however, the etiology of the symptoms can be delineated, separate disability evaluations may be assigned under multiple DCs for foot disabilities provided that the principles of <a href=\"https://www.ecfr.gov/cgi-bin/text-idx?SID=019403379b9d4d1c9aae93e88d236cae&amp;mc=true&amp;node=se38.1.4_114&amp;rgn=div8\" target=\"_blank\">38 CFR 4.14</a> have not been violated.   </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>Reference</em></strong>:  For more information on evaluating SC and non-service-connected (NSC) symptoms that cannot be separated, see <a articleid=\"554400000180489\" articlename=\"M21-1, Part V, Subpart ii, Chapter 3, Section D - Evaluating Disabilities\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000180489/M21-1-Part-V-Subpart-ii-Chapter-3-Section-D-Evaluating-Disabilities\">M21-1, Part V, Subpart ii, 3.D.2.c</a>.</span></span></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">V.iii.1.B.5.d<a id=\"5d\" name=\"5d\">.</a>  Evaluating Arthritis of the Minor Joints of the Toes</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">For guidance on evaluating arthritis of a group of minor joints of the toes refer to the table below.</span></span></div><div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">  </span></span></div><table border=\"1\" cellpadding=\"1\" cellspacing=\"1\" style=\"width: 510px; border-spacing: 1px; border-collapse: revert;\" summary=\"This is an If-Then table.  Column 1 provides the criteria and column 2 provides the actions to take when evaluating arthritis of a group of minor joints of the toes.\" width=\"510\"><thead><tr><th scope=\"col\" style=\"width: 258px; padding: 1px;\"><div style=\"text-align: left\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong>If arthritis ...</strong></span></span></div></th><th scope=\"col\" style=\"width: 252px; padding: 1px;\"><div style=\"text-align: left\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong>Then ...</strong></span></span></div></th></tr></thead><tbody><tr><td style=\"width: 258px; padding: 1px;\"><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">is degenerative</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">affects a group of minor joints in one foot</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">is documented by x-ray evidence</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">results in LOM, <strong><em>and</em></strong></span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">is confirmed by satisfactory evidence of painful motion, pain on use or other findings such as swelling</span></span></div></li></ul></td><td style=\"width: 252px; vertical-align: top; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">assign a 10-percent evaluation under <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=2ec7350adee36049b3011df9cfd38f55&amp;node=se38.1.4_171a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.71a, DC 5003</a>.</span></span></div></td></tr><tr><td style=\"width: 258px; padding: 1px;\"><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">is degenerative</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">affects minor joint groups in <em>both</em> feet, <strong><em>and</em></strong></span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">is documented by x-ray evidence, <strong><em>but</em></strong></span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">does not result in LOM</span></span></div></li></ul></td><td style=\"width: 252px; vertical-align: top; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">assign a 10-percent evaluation under <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=2ec7350adee36049b3011df9cfd38f55&amp;node=se38.1.4_171a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.71a, DC 5003</a>.</span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>Exception</em></strong>:  Assign a 20-percent evaluation if there are occasional incapacitating exacerbations).</span></span></div></td></tr><tr><td style=\"width: 258px; vertical-align: top; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">is post-traumatic</span></span></div></td><td style=\"width: 252px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">evaluate under <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=2ec7350adee36049b3011df9cfd38f55&amp;node=se38.1.4_171a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.71a, DC 5010-5284</a> with consideration given to <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=ff07c75cd57bc7c5816feafc92fa44e0&amp;node=se38.1.4_159&amp;rgn=div8\" target=\"_blank\">38 CFR 4.59</a> when warranted.</span></span></div></td></tr></tbody></table></div><div></div><div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>References</em></strong>:  For more information on </span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">assigning evaluations under <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=2ec7350adee36049b3011df9cfd38f55&amp;node=se38.1.4_171a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.71a, DC 5003</a> when a compensable rating cannot be assigned under a DC for LOM of a joint, see <a articleid=\"554400000014413\" articlename=\"M21-1, Part V, Subpart iii, Chapter 1, Section C - Arthritis\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000014413/M21-1-Part-V-Subpart-iii-Chapter-1-Section-C-Arthritis\">M21-1, Part V, Subpart iii, 1.C.4.b</a>, and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">considering painful motion when evaluating functional loss for purpose of applying <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=2ec7350adee36049b3011df9cfd38f55&amp;node=se38.1.4_171a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.71a, DC 5003</a>, pursuant to the holding in <a articleid=\"554400000014394\" articlename=\"Mitchell v. Shinseki, Aug 23, 2011, 25 Vet.App. 32\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000014394/Mitchell-v-Shinseki-Aug-23-2011-25-VetApp-32\"><em>Mitchell v. Shinseki</em></a>, 25 Vet.App. 32 (2011), see <a articleid=\"554400000014407\" articlename=\"M21-1, Part V, Subpart iii, Chapter 1, Section A - Painful Motion and Functional Loss\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000014407/M21-1-Part-V-Subpart-iii-Chapter-1-Section-A-Painful-Motion-and-Functional-Loss\">M21-1, Part V, Subpart iii, 1.A.1.e</a>.</span></span></div></li></ul></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">V.iii.1.B.5.e<a id=\"5e\" name=\"5e\">.</a> Evaluating Plantar Fasciitis</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Evaluate plantar fasciitis under <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=f0ba792d9e43f57d3adb80c97fde7df9&amp;node=se38.1.4_171a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.71a, DC 5269</a>.</span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">The most common symptom seen with plantar fasciitis is heel pain.  The following considerations apply when evaluating the heel pain.</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">When painful motion with joint or periarticular pathology is present and is a symptom of the plantar fasciitis, <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=2ec7350adee36049b3011df9cfd38f55&amp;node=se38.1.4_159&amp;rgn=div8\" target=\"_blank\">38 CFR 4.59</a> is applicable.  However,  at least a 10-percent evaluation would most often be warranted under <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=f0ba792d9e43f57d3adb80c97fde7df9&amp;node=se38.1.4_171a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.71a, DC 5269</a> without consideration of <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=2ec7350adee36049b3011df9cfd38f55&amp;node=se38.1.4_159&amp;rgn=div8\" target=\"_blank\">38 CFR 4.59</a>.</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">When SC is established for pes planus and plantar fasciitis, evaluate the symptoms of both conditions together under the DC warranting the highest evaluation for the combined impairment.</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Pes planus is characterized by pain on manipulation and use of the feet or other foot pain as included in the higher evaluation criteria.  The evaluation criteria for pes planus and plantar fasciitis are similar enough that providing separate evaluations will compensate the same facet of disability, foot pain, violating the prohibition against pyramiding in <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=2ec7350adee36049b3011df9cfd38f55&amp;node=se38.1.4_114&amp;rgn=div8\" target=\"_blank\">38 CFR 4.14</a>.</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">If, however, one or both conditions resulted from an injury to the foot, an evaluation for the combined conditions under <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=2ec7350adee36049b3011df9cfd38f55&amp;node=se38.1.4_171a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.71a, DC 5284</a> may be assigned in lieu of evaluation under either the pes planus or plantar fasciitis criteria when doing so is  more advantageous.</span></span></div></li></ul></li></ul><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>Reference</em></strong>:  For more information on rating by analogy, see </span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a articleid=\"554400000180525\" articlename=\"M21-1, Part V, Subpart iv, Chapter 1, Section C - Coded Conclusion\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000180525/M21-1-Part-V-Subpart-iv-Chapter-1-Section-C-Coded-Conclusion\">M21-1, Part V, Subpart iv, 1.C.2</a>, and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a articleid=\"554400000180489\" articlename=\"M21-1, Part V, Subpart ii, Chapter 3, Section D - Evaluating Disabilities\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000180489/M21-1-Part-V-Subpart-ii-Chapter-3-Section-D-Evaluating-Disabilities\">M21-1, Part V, Subpart ii, 3.D.1.c</a>.</span></span></div></li></ul></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\">V.iii.1.B.5.f<a id=\"5f\" name=\"5f\">.</a>  Definition of Metatarsalgia or Morton’s Disease</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; vertical-align: top; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>Metatarsalgia</em></strong> means pain in the forefoot – under the metatarsal heads. </span></span></div><div></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>Morton’s Disease</em></strong> or <strong><em>Morton’s Neuroma</em></strong> refers to a painful lesion of a plantar interdigital nerve.  </span></span></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">V.iii.1.B.5.g<a id=\"5g\" name=\"5g\">.</a> Evaluating Metatarsalgia or Morton’s Disease</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; vertical-align: top; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Anterior metatarsalgia of any type, to include cases due to Morton’s Disease, will be evaluated under <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=2ec7350adee36049b3011df9cfd38f55&amp;node=se38.1.4_171a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.71a, DC 5279</a>. </span></span></div><div></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">The DC provides for an evaluation of 10 percent regardless of whether the condition is unilateral or bilateral.  </span></span></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">V.iii.1.B.5.h<a id=\"5h\" name=\"5h\">.</a>  Evaluating Metatarsalgia and Plantar Fasciitis</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; vertical-align: top; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Since metatarsalgia refers to pain in the forefoot while plantar fasciitis is associated with pain in the heel, the symptoms should generally not overlap and separate evaluations may be assigned <em>unless</em> assessment of the evidence reveals that separate evaluation would be in violation of the pyramiding rules at <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=2ec7350adee36049b3011df9cfd38f55&amp;node=se38.1.4_114&amp;rgn=div8\" target=\"_blank\">38 CFR 4.14</a>.</span></span></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">V.iii.1.B.5.i<a id=\"5i\" name=\"5i\">.</a>  Evaluating Metatarsalgia and Pes Planus</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Do not assign separate evaluations for pes planus and metatarsalgia.</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Pes planus is accompanied by pain on manipulation and use of the feet or other foot pain, as included in the higher evaluation criteria.  The evaluation criteria are similar enough that providing separate evaluations will compensate the same facet of disability, foot pain, violating the prohibition against pyramiding in <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=2ec7350adee36049b3011df9cfd38f55&amp;node=se38.1.4_114&amp;rgn=div8\" target=\"_blank\">38 CFR 4.14</a>. </span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Assign a single evaluation for pes planus with metatarsalgia using the predominant DC. </span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Do not rate by analogy when there is an applicable DC. </span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">If, however, one or both conditions resulted from an injury to the foot,  an evaluation for the combined conditions under <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=2ec7350adee36049b3011df9cfd38f55&amp;node=se38.1.4_171a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.71a, DC 5284</a> may be assigned in lieu of evaluation under either the pes planus or metatarsalgia criteria when doing so is more advantageous. </span></span></div></li></ul></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><p class=\"ng-scope\" style=\"text-align: right\"><span style=\"font-size: 11px\"><span style=\"font-family: arial , helvetica , sans-serif\"><a articleid=\"554400000014407\" articlename=\"M21-1, Part V, Subpart iii, Chapter 1, Section A - Painful Motion and Functional Loss\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000014407/M21-1-Part-V-Subpart-iii-Chapter-1-Section-A-Painful-Motion-and-Functional-Loss\">&lt;-- Previous Section</a>  <a articleid=\"554400000014413\" articlename=\"M21-1, Part V, Subpart iii, Chapter 1, Section C - Arthritis\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000014413/M21-1-Part-V-Subpart-iii-Chapter-1-Section-C-Arthritis\">Next Section --&gt;</a></span></span></p><p class=\"ng-scope\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#top\" target=\"_self\"><span style=\"font-size: 11px\">To Top</span></a></span></span></span></p><p class=\"ng-scope\"></p></div>\n</div>",
  "external_links": [
    "http://vbaw.vba.va.gov/bl/21/advisory/CAVCDAD.htm#bmy",
    "http://www.ecfr.gov/cgi-bin/text-idx?SID=06267d0544c9650e626f1fe90192edac&node=se38.1.4_171a&rgn=div8",
    "http://www.ecfr.gov/cgi-bin/text-idx?SID=0bd8cbf4ebf7f012b8415b710ea821da&mc=true&node=se38.1.4_171a&rgn=div8",
    "http://www.ecfr.gov/cgi-bin/text-idx?SID=0d5268726d8c1566de1c1953d5a9c573&node=se38.1.4_169&rgn=div8",
    "http://www.ecfr.gov/cgi-bin/text-idx?SID=13bcad22732de2e24d3da7cad62932d5&node=se38.1.4_171a&rgn=div8",
    "http://www.ecfr.gov/cgi-bin/text-idx?SID=1fb629056852366ecec871c9d143e8a8&mc=true&node=se38.1.4_171a&rgn=div8",
    "http://www.ecfr.gov/cgi-bin/text-idx?SID=2375abdd93d9ea77dbeab85b13dc534b&node=se38.1.4_171a&rgn=div8",
    "http://www.ecfr.gov/cgi-bin/text-idx?SID=2dd5087eef182bbdf97785fdbb1c3381&node=se38.1.4_171a&rgn=div8",
    "http://www.ecfr.gov/cgi-bin/text-idx?SID=2ec7350adee36049b3011df9cfd38f55&node=se38.1.4_114&rgn=div8",
    "http://www.ecfr.gov/cgi-bin/text-idx?SID=2ec7350adee36049b3011df9cfd38f55&node=se38.1.4_159&rgn=div8",
    "http://www.ecfr.gov/cgi-bin/text-idx?SID=2ec7350adee36049b3011df9cfd38f55&node=se38.1.4_171a&rgn=div8",
    "http://www.ecfr.gov/cgi-bin/text-idx?SID=40fc1e088ec92f168f9d24242bd432e7&mc=true&node=se38.1.4_125&rgn=div8",
    "http://www.ecfr.gov/cgi-bin/text-idx?SID=70df8a154d2bdffaab9f94956057a637&node=pt38.1.4&rgn=div5#se38.1.4_171a",
    "http://www.ecfr.gov/cgi-bin/text-idx?SID=70df8a154d2bdffaab9f94956057a637&node=se38.1.4_114&rgn=div8",
    "http://www.ecfr.gov/cgi-bin/text-idx?SID=70df8a154d2bdffaab9f94956057a637&node=se38.1.4_140&rgn=div8",
    "http://www.ecfr.gov/cgi-bin/text-idx?SID=70df8a154d2bdffaab9f94956057a637&node=se38.1.4_145&rgn=div8",
    "http://www.ecfr.gov/cgi-bin/text-idx?SID=7cfdb4f1b10584057cd96f9f5c031c61&mc=true&node=se38.1.4_131&rgn=div8",
    "http://www.ecfr.gov/cgi-bin/text-idx?SID=a25f6b8117934a9ebee262b5ec0a0a60&mc=true&node=se38.1.4_120&rgn=div8",
    "http://www.ecfr.gov/cgi-bin/text-idx?SID=b563d2caeb25864bc9eba141a3d9f64e&node=se38.1.4_1124a&rgn=div8",
    "http://www.ecfr.gov/cgi-bin/text-idx?SID=e8fdbb668d97e82f2406bf2c4a1bc49f&node=se38.1.4_171a&rgn=div8",
    "http://www.ecfr.gov/cgi-bin/text-idx?SID=e946814d91c13a689fba4efddae34bc3&mc=true&node=se38.1.4_171a&rgn=div8",
    "http://www.ecfr.gov/cgi-bin/text-idx?SID=f0ba792d9e43f57d3adb80c97fde7df9&node=se38.1.4_171a&rgn=div8",
    "http://www.ecfr.gov/cgi-bin/text-idx?SID=ff07c75cd57bc7c5816feafc92fa44e0&node=se38.1.4_159&rgn=div8",
    "http://www.gpo.gov/fdsys/pkg/CFR-2003-title38-vol1/pdf/CFR-2003-title38-vol1-part4.pdf",
    "http://www.gpo.gov/fdsys/pkg/CFR-2009-title38-vol1/xml/CFR-2009-title38-vol1-sec3-157.xml",
    "https://www.ecfr.gov/cgi-bin/retrieveECFR?gp=&SID=dcc466c3e069a06e73c46e3cc158e2b8&mc=true&n=sp38.1.4.b&r=SUBPART&ty=HTML#se38.1.4_159",
    "https://www.ecfr.gov/cgi-bin/text-idx?SID=019403379b9d4d1c9aae93e88d236cae&mc=true&node=se38.1.4_114&rgn=div8",
    "https://www.ecfr.gov/cgi-bin/text-idx?SID=03c3db765ef22fc0b2754142e5591059&mc=true&node=se38.1.4_173&rgn=div8",
    "https://www.ecfr.gov/cgi-bin/text-idx?SID=1b780b2c30613fbf044bcf8e86b6fc85&pitd=20150101&node=se38.1.3_1157&rgn=div8",
    "https://www.ecfr.gov/cgi-bin/text-idx?SID=2375abdd93d9ea77dbeab85b13dc534b&node=se38.1.4_120&rgn=div8",
    "https://www.ecfr.gov/cgi-bin/text-idx?SID=38d7ed71833e3104d61f4357b9e82e8f&mc=true&node=se38.1.3_1309&rgn=div8",
    "https://www.ecfr.gov/cgi-bin/text-idx?SID=5b5a1f4fd2d936fa785c43b86106f080&mc=true&node=se38.1.4_114&rgn=div8",
    "https://www.ecfr.gov/cgi-bin/text-idx?SID=70df8a154d2bdffaab9f94956057a637&node=se38.1.4_114&rgn=div8",
    "https://www.ecfr.gov/cgi-bin/text-idx?SID=70df8a154d2bdffaab9f94956057a637&node=se38.1.4_159&rgn=div8",
    "https://www.ecfr.gov/cgi-bin/text-idx?SID=723bf010a2bbd949375ecb0617db622e&mc=true&node=se38.1.4_159&rgn=div8",
    "https://www.ecfr.gov/cgi-bin/text-idx?SID=b666bbcef57d8aca78c2a5cb028975bb&mc=true&node=se38.1.4_140&rgn=div8",
    "https://www.ecfr.gov/cgi-bin/text-idx?SID=b666bbcef57d8aca78c2a5cb028975bb&mc=true&node=se38.1.4_145&rgn=div8",
    "https://www.ecfr.gov/cgi-bin/text-idx?SID=dcc466c3e069a06e73c46e3cc158e2b8&mc=true&node=se38.1.4_171a&rgn=div8",
    "https://www.ecfr.gov/current/title-38/section-3.155",
    "https://www.ecfr.gov/current/title-38/section-4.124a",
    "https://www.ecfr.gov/current/title-38/section-4.14",
    "https://www.ecfr.gov/current/title-38/section-4.71a",
    "https://www.ecfr.gov/on/2024-07-22/title-38/section-3.155",
    "https://www.ecfr.gov/on/2024-08-20/title-38/section-3.400",
    "https://www.ecfr.gov/on/2024-08-22/title-38/section-3.400",
    "https://www.vba.va.gov/pubs/forms/VBA-21-526EZ-ARE.pdf"
  ],
  "scraped_at": "2025-06-16T22:43:15.998943",
  "next_section": "https://www.knowva.ebenefits.va.gov/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000014413/M21-1-Part-V-Subpart-iii-Chapter-1-Section-C-Arthritis"
}